var title_f0_34_544="Borrelia lonestari";
var content_f0_34_544=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    B. lonestari",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of Borrelia lonestari growing in tissue culture using ISE6 tick tissue culture (Giemsa stain).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Susan Little, DVM.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_544=[""].join("\n");
var outline_f0_34_544=null;
var title_f0_34_545="Inflammatory breast cancer";
var content_f0_34_545=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65383&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory breast cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    It is important to rule out inflammatory breast cancer if a suspected breast infection does not respond to antibiotics.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Dixon, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_545=[""].join("\n");
var outline_f0_34_545=null;
var title_f0_34_546="TB of the spine Pott disease";
var content_f0_34_546=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F86251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F86251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Tuberculosis of the spine (Pott disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 492px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MRI with T1 weighted fat saturated image showing anterior vertebral body destruction with relative sparing of adjacent discs and an abscess spreading beneath the anterior longitudinal ligament.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Denis Spelman, MBBS, FRACP, FRCPA, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_546=[""].join("\n");
var outline_f0_34_546=null;
var title_f0_34_547="Patient information: Sjgrens syndrome (The Basics)";
var content_f0_34_547=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85725\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/13/43216\">",
"         Moisture chambers",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?29/46/30433\">",
"         Patient information: Dry eye (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/20/43329\">",
"         Patient information: Fibromyalgia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/42/22178\">",
"         Patient information: Lupus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/31/16883\">",
"         Patient information: Rheumatoid arthritis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/23/28017\">",
"         Patient information: Scleroderma (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/17/11538\">",
"         Patient information: Sex problems in women (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/17/24854\">",
"         Patient information: Fibromyalgia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/16/2306\">",
"         Patient information: Insomnia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/11/44212\">",
"         Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/23/7537\">",
"         Patient information: Vaginal dryness (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Sj&ouml;gren&rsquo;s syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/sjogrens-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H74095171\">",
"      <span class=\"h1\">",
"       What is Sj&ouml;gren&rsquo;s syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sj&ouml;gren&rsquo;s syndrome is a disease that causes dry eyes, dry mouth, and other symptoms. It happens when the body&rsquo;s infection-fighting system (called the &ldquo;immune system&rdquo;) attacks glands that keep the eyes, mouth, and other parts of the body moist. &nbsp; &nbsp;",
"     </p>",
"     <p>",
"      Some people with Sj&ouml;gren&rsquo;s syndrome have other immune system conditions. These include rheumatoid arthritis, lupus, and scleroderma. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095186\">",
"      <span class=\"h1\">",
"       What are the symptoms of Sj&ouml;gren&rsquo;s syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main symptoms are dry eyes and dry mouth. Dry eye symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eyes that feel dry or burn",
"       </li>",
"       <li>",
"        A sandy or gritty feeling in the eyes",
"       </li>",
"       <li>",
"        Red or watery eyes",
"       </li>",
"       <li>",
"        Blurry vision",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have a dry mouth, you might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Wake up at night to drink water because your mouth is so dry",
"       </li>",
"       <li>",
"        Need to drink liquids to help swallow dry foods",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sj&ouml;gren&rsquo;s syndrome can also affect other parts of the body. Symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Dry, itchy skin",
"       </li>",
"       <li>",
"        Joint or muscle pain",
"       </li>",
"       <li>",
"        Problems urinating, such as:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Pain",
"       </li>",
"       <li>",
"        Urinating more often than usual",
"       </li>",
"       <li>",
"        Getting up a lot at night to urinate",
"       </li>",
"       <li>",
"        Needing to urinate suddenly",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Tiredness",
"       </li>",
"       <li>",
"        Vaginal dryness &ndash; This can make sex painful.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095201\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will learn about your symptoms and do an exam. You might also have the following tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eye tests &ndash; To check if your eyes are making a normal amount of tears. If not, this could be a sign of Sj&ouml;gren&rsquo;s syndrome. An eye doctor called an &ldquo;ophthalmologist&rdquo; does these tests.",
"       </li>",
"       <li>",
"        Blood and urine tests &ndash; To check for diseases that people with Sj&ouml;gren&rsquo;s syndrome often have or other conditions that could be causing symptoms. &nbsp;",
"       </li>",
"       <li>",
"        A test called a &ldquo;biopsy&rdquo; &ndash; In this test, a doctor takes a small sample of tissue from inside your lower lip. Another doctor looks at it under a microscope for signs of Sj&ouml;gren&rsquo;s syndrome.",
"       </li>",
"       <li>",
"        MRI &ndash; This test uses special magnets and radio waves to create pictures of the inside of the body. Doctors can use it to look at the saliva glands in your mouth.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095218\">",
"      <span class=\"h1\">",
"       How is Sj&ouml;gren&rsquo;s syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Dry eye treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eye ointments and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?3/31/3572?source=see_link\">",
"         artificial tears",
"        </a>",
"        &ndash; Your doctor or nurse will help you decide which ones are best for you.",
"       </li>",
"       <li>",
"        A procedure called &ldquo;punctal occlusion&rdquo; &ndash; In this procedure, an ophthalmologist puts tiny plugs in the tubes that normally drain tears from the eye. This can help with dry eyes by keeping tears on the eye longer.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Dry mouth treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Sprays and lozenges",
"       </li>",
"       <li>",
"        Prescription medicines you take by mouth",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines to relieve other symptoms of Sj&ouml;gren&rsquo;s syndrome or problems it can cause. For example, if you have joint pain, you can try",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;) or",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sample brand name: Aleve&reg;).",
"       </li>",
"       <li>",
"        Medicines that partly &ldquo;turn off&rdquo; the immune system",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095233\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Sip water, chew sugarless gum, or suck sugar-free candy to help with dry mouth. If you don&rsquo;t like drinking a lot of water, you can rinse your mouth and spit the water out.",
"       </li>",
"       <li>",
"        Put lip balm on dry lips and moisturizer on dry skin.",
"       </li>",
"       <li>",
"        Avoid excess air conditioning or heating. Use a humidifier in your bedroom and other places where you spend a lot of time.",
"       </li>",
"       <li>",
"        Use &ldquo;moisture chambers&rdquo; if your doctor or nurse suggests them. Moisture chambers are devices that fit on your glasses. They can help keep your eyes moist (",
"        <a class=\"graphic graphic_picture graphicRef82900 \" href=\"UTD.htm?42/13/43216\">",
"         picture 1",
"        </a>",
"        ). You can buy them at most stores that sell glasses.",
"       </li>",
"       <li>",
"        Brush and floss your teeth after every meal, and see your dentist as often as your doctor or nurse tells you. Dry mouth raises the risk of cavities and some other mouth problems. &nbsp; &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095248\">",
"      <span class=\"h1\">",
"       What else should I know about Sj&ouml;gren&rsquo;s syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you need surgery, make sure the doctor who gives you anesthesia (called an &ldquo;anesthesiologist&rdquo;) knows you have Sj&ouml;gren&rsquo;s syndrome. Having Sj&ouml;gren&rsquo;s syndrome can increase the risk of certain problems during surgery. Knowing you have Sj&ouml;gren&rsquo;s syndrome helps doctors do things to lower the risk of problems. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H74095265\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/46/30433?source=see_link\">",
"       Patient information: Dry eye (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/20/43329?source=see_link\">",
"       Patient information: Fibromyalgia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/42/22178?source=see_link\">",
"       Patient information: Lupus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/31/16883?source=see_link\">",
"       Patient information: Rheumatoid arthritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/23/28017?source=see_link\">",
"       Patient information: Scleroderma (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/17/11538?source=see_link\">",
"       Patient information: Sex problems in women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/17/24854?source=see_link\">",
"       Patient information: Fibromyalgia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/16/2306?source=see_link\">",
"       Patient information: Insomnia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=see_link\">",
"       Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7537?source=see_link\">",
"       Patient information: Vaginal dryness (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?0/34/547?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85725 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-C5FDE4D645-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_547=[""].join("\n");
var outline_f0_34_547=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095171\">",
"      What is Sj&ouml;gren&rsquo;s syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095186\">",
"      What are the symptoms of Sj&ouml;gren&rsquo;s syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095201\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095218\">",
"      How is Sj&ouml;gren&rsquo;s syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095233\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095248\">",
"      What else should I know about Sj&ouml;gren&rsquo;s syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H74095265\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85725\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/13/43216\">",
"      Moisture chambers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/46/30433?source=related_link\">",
"      Patient information: Dry eye (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/17/24854?source=related_link\">",
"      Patient information: Fibromyalgia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/20/43329?source=related_link\">",
"      Patient information: Fibromyalgia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/16/2306?source=related_link\">",
"      Patient information: Insomnia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/42/22178?source=related_link\">",
"      Patient information: Lupus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/31/16883?source=related_link\">",
"      Patient information: Rheumatoid arthritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/23/28017?source=related_link\">",
"      Patient information: Scleroderma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/17/11538?source=related_link\">",
"      Patient information: Sex problems in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=related_link\">",
"      Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/23/7537?source=related_link\">",
"      Patient information: Vaginal dryness (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_548="Duodenum in scleroderma Light";
var content_f0_34_548=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Duodenum in scleroderma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Section of duodenum from a patient with scleroderma (Masson trichrome stain). There is normal villus structure and epithelial cell morphology (right side), a mild inflammatory cell infiltrate in the lamina propria, collagen (seen in dark blue) encapsulating Brunner's glands, and fibrous replacement of the muscularis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD, FRCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_548=[""].join("\n");
var outline_f0_34_548=null;
var title_f0_34_549="MRI breast cancer";
var content_f0_34_549=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Breast MRI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 212px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Staging breast magnetic resonance image (MRI) for invasive carcinoma poorly assessed on mammography. (A) Preconstrast 3-D FSPGR MRI image with fat suppression. (B) Postcontrast MRI delineates the extent of the invasive carcinoma as well as several clinically and mammographically occult satelite lesions (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stomper, PC. Breast Imaging. In: Atlas of Breast Cancer, 2nd edition, Hayes, DF (Ed), Mosby, New York 2000. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_549=[""].join("\n");
var outline_f0_34_549=null;
var title_f0_34_550="Indomethacin: Patient drug information";
var content_f0_34_550=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Indomethacin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     see \"Indomethacin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     see \"Indomethacin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Indocin&reg;;",
"     </li>",
"     <li>",
"      Indocin&reg; I.V.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Indomethacin&reg;;",
"     </li>",
"     <li>",
"      Indocid&reg; P.D.A.;",
"     </li>",
"     <li>",
"      Novo-Methacin;",
"     </li>",
"     <li>",
"      Nu-Indo;",
"     </li>",
"     <li>",
"      Pro-Indo;",
"     </li>",
"     <li>",
"      ratio-Indomethacin;",
"     </li>",
"     <li>",
"      Sandoz-Indomethacin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain, swelling, and fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691647",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop early labor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702301",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to indomethacin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use suppository rectally.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Capsule:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705560",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Suppository:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10761 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.146-1B4384F6EC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_550=[""].join("\n");
var outline_f0_34_550=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182656\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182657\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029810\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029812\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029811\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029816\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029817\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029819\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029814\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029815\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029820\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029821\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=related_link\">",
"      Indomethacin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=related_link\">",
"      Indomethacin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_551="Chagas disease: Natural history and diagnosis";
var content_f0_34_551=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chagas disease: Natural history and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/551/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/551/contributors\">",
"     Caryn Bern, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/551/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/551/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/551/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/551/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/34/551/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H541206302\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi; the major manifestations are Chagas cardiomyopathy and gastrointestinal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/1\">",
"     1",
"    </a>",
"    ]. Issues related to the natural history of infection, diagnosis, and clinical circumstances will be reviewed here. Other issues related to Chagas disease, including cardiac and gastrointestinal involvement, are discussed in detail separately. (See related topics).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206310\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206318\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humans and other mammals usually become infected when the triatomine vector defecates during its blood meal, and fecal material containing the parasite is inoculated through the bite wound or mucous membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/2\">",
"     2",
"    </a>",
"    ]. Transmission can also occur congenitally from mother to infant, via transfusion of blood components, via transplantation of an organ from an infected donor, and via consumption of contaminated food or drink. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23880?source=see_link\">",
"     \"Epidemiology and control of Chagas disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206326\">",
"    <span class=\"h2\">",
"     Acute phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period following exposure is one to two weeks, after which the acute phase of Chagas disease begins. In the setting of transfusion- and transplant-associated cases, the incubation period may be as long as four months [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The acute phase of T. cruzi infection lasts 8 to 12 weeks and is characterized by circulating trypomastigotes detectable by microscopy of fresh blood or buffy coat smears (",
"    <a class=\"graphic graphic_picture graphicRef60060 \" href=\"UTD.htm?14/16/14593\">",
"     picture 1",
"    </a>",
"    ). Most patients have only mild, non-specific symptoms such as fever or are asymptomatic, so do not come to clinical attention during the acute phase.",
"   </p>",
"   <p>",
"    In a minority of patients, acute infection may be associated with inflammation and swelling at the site of inoculation, known as a chagoma. Chagomas typically occur on the face or extremities; in some cases, parasites can be demonstrated in the lesion. Inoculation via the conjunctiva may lead to a characteristic unilateral swelling of the upper and lower eyelid known as Roma&ntilde;a's sign (",
"    <a class=\"graphic graphic_picture graphicRef58601 \" href=\"UTD.htm?11/27/11711\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Severe acute disease occurs in less than 1 percent of patients; manifestations may include acute myocarditis, pericardial effusion,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    meningoencephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. Severe acute Chagas disease carries a substantial risk of mortality. Orally-transmitted T. cruzi infection appears to be associated with more severe acute morbidity and higher mortality rate than vector-borne infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to treatment of acute Chagas disease are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060876#H107060876\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Acute Chagas disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206333\">",
"    <span class=\"h2\">",
"     Congenital Chagas disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1 to 10 percent of infants of infected mothers are born with acute T. cruzi infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. Most congenital T. cruzi infections are asymptomatic or cause non-specific signs; laboratory screening is required for detection of these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. In a small proportion of patients, congenital infection causes severe morbidity, including low birthweight, hepatosplenomegaly, anemia, meningoencephalitis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    respiratory insufficiency, with high mortality risk [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. Infants who survive acute infection are presumed to carry the same lifetime risk of cardiac or gastrointestinal disease as other infected individuals (20 to 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/2\">",
"     2",
"    </a>",
"    ]. Identification of infection in a woman should prompt testing of all of her children. There are data suggesting that a woman with one infected infant may have a higher risk of transmitting to subsequent children [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to treatment of congenital Chagas disease are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060876#H107060876\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Acute Chagas disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206350\">",
"    <span class=\"h2\">",
"     Chronic phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronic phase begins once parasitemia falls below levels detectable by microscopy; in the absence of antitrypanosomal therapy, this usually occurs 8 to 12 weeks after the onset of infection. Individuals with chronic T. cruzi infection are capable of transmitting the parasite to the insect vector and directly to other humans via blood components, organ donation, or transplacentally, even in the absence of clinical manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/2,14\">",
"     2,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation and management of patients with chronic Chagas are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060891#H107060891\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Chronic Chagas disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206357\">",
"    <span class=\"h3\">",
"     Indeterminate form",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the indeterminate form of chronic T. cruzi infection have positive tests for anti-T. cruzi antibodies but no signs or symptoms of Chagas cardiomyopathy or gastrointestinal disease. Such patients have normal 12-lead electrocardiogram (ECG) findings and normal radiological examination of the chest, esophagus, and colon [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/15\">",
"     15",
"    </a>",
"    ]. As gastrointestinal Chagas disease is rare, especially outside of the Southern Cone countries (Bolivia, Argentina, Paraguay, Chile, Brazil), guidelines in the United States advocate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    studies only in patients with gastrointestinal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    About 20 to 30 percent of individuals with the indeterminate form of Chagas disease progress over a period of years to decades to clinically evident disease. The approach to antitrypanosomal therapy for patients with the indeterminate form of Chagas disease is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060907#H107060907\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Antitrypanosomal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206364\">",
"    <span class=\"h3\">",
"     Heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chagas heart disease develops more commonly than gastrointestinal disease. Issues related to Chagas heart disease are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=see_link&amp;anchor=H372251508#H372251508\">",
"     \"Treatment and prognosis of Chagas heart disease\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206372\">",
"    <span class=\"h3\">",
"     Gastrointestinal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to Chagas gastrointestinal disease are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=see_link\">",
"     \"Gastrointestinal Chagas disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206379\">",
"    <span class=\"h3\">",
"     Reactivation due to immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactivation of chronic T. cruzi infection can occur in patients with immunosuppression due to malignancy, chemotherapy, immunosuppressive regimens for solid organ or bone marrow transplantation, or",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/17-28\">",
"     17-28",
"    </a>",
"    ]. Clinical findings and management are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060914#H107060914\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Immunosuppression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206387\">",
"    <span class=\"h1\">",
"     LABORATORY DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206395\">",
"    <span class=\"h2\">",
"     Acute phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the acute phase, the level of parasitemia is high; motile trypomastigotes can be detected by microscopy of fresh preparations of anticoagulated blood or buffy coat [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/14\">",
"     14",
"    </a>",
"    ]. The level of parasitemia decreases within 90 days of infection, even without treatment, and is undetectable by microscopy in the chronic phase [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/14,29\">",
"     14,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PCR is a sensitive diagnostic tool in the acute phase of Chagas disease. It may also be used to monitor for acute T. cruzi infection in the recipient of an infected organ or after accidental exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/4,30\">",
"     4,30",
"    </a>",
"    ]. PCR assays generally demonstrate positive results days to weeks before circulating trypomastigotes are detectable on peripheral blood smears [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206403\">",
"    <span class=\"h2\">",
"     Congenital Chagas disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technique traditionally used to diagnose congenital T. cruzi infection is micromethod (or microhematocrit method) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/10,32,33\">",
"     10,32,33",
"    </a>",
"    ]. This technique consists of centrifugation of fresh cord or neonatal blood sealed in four to six heparinized microhematocrit tubes (12,000 rpm for 7 minutes), followed by light microscopic examination of the buffy coat layer [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/32\">",
"     32",
"    </a>",
"    ]. However, the sensitivity of examination of a single infant specimen by this technique is less than 50 percent; repeated sampling may increase the sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Molecular techniques have substantially higher sensitivity and detect congenital infections earlier in life compared with the micromethod [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/8,34,35\">",
"     8,34,35",
"    </a>",
"    ]. Although not yet widely implemented in the context of congenital Chagas disease screening programs, PCR is increasingly used for the early diagnosis of congenital Chagas disease in Latin America and is the method of choice in industrialized countries [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/11,35-38\">",
"     11,35-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For infants not diagnosed at birth, conventional IgG serology is recommended after nine months of age, when transferred maternal antibody has disappeared [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/8,36\">",
"     8,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206420\">",
"    <span class=\"h2\">",
"     Chronic phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of chronic infection requires serological methods to detect IgG antibodies to T. cruzi, most commonly enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody assay (IFA). No available assay has sufficient sensitivity and specificity to be used alone; a single positive result does not constitute a confirmed diagnosis. Two serological tests based on different antigens (eg, whole parasite lysate and recombinant antigens)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    techniques (eg, ELISA and IFA) are used in parallel to increase the accuracy of the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/14\">",
"     14",
"    </a>",
"    ]. Data suggest that the sensitivity of serological assays varies by geographical location, possibly due to T. cruzi strain differences and resulting antibody responses [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/39-41\">",
"     39-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals tested by two serological assays with discordant results require further testing. In some cases, the infection status remains difficult to resolve even after a third test, because there is no true gold standard assay for chronic T. cruzi infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/42\">",
"     42",
"    </a>",
"    ]. Assays such as the radioimmune precipitation assay (RIPA) and trypomastigote excreted-secreted antigen immunoblot (TESA-blot) are promoted as reference tests, but even these do not have optimal sensitivity and specificity and may not be capable of resolving the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Options for T. cruzi serological testing in the United States are relatively limited. Several diagnostic ELISA kits based on parasite lysate or recombinant antigens are FDA cleared. Use of an assay with validation data (eg, a commercial kit shown to have acceptable sensitivity and specificity in a thorough study) is preferable to reliance on in-house tests, for which no performance data are publicly available.",
"   </p>",
"   <p>",
"    The Centers for Disease Control (CDC) provides consultation to health care providers concerning Chagas disease diagnostic testing and acts as a reference laboratory for Chagas disease serology and PCR (Division of Parasitic Diseases Public Inquiries line, 404-718-4745; for emergencies after business hours, 770-488-7100; email parasites@cdc.gov).",
"   </p>",
"   <p>",
"    In general, PCR is not a useful diagnostic test for chronic T. cruzi infection. The sensitivity is highly variable and depends on patient characteristics as well as PCR primers and methods [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Direct demonstration of parasite by hemoculture or xenodiagnosis in a reliable laboratory indicates true infection, although the sensitivity of these techniques in chronic T. cruzi infection is generally less than 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Hemoculture consists of inoculation of a small volume (eg, 0.2 cc) of whole blood or buffy coat in a standard parasitic medium such as Novy-MacNeal-Nicolle (NNN), followed by incubation at 28&deg;C [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/50\">",
"     50",
"    </a>",
"    ]. Microscopic examination for motile epimastigotes is performed at 14 days and then weekly until at least 35 days post-inoculation. &nbsp;",
"   </p>",
"   <p>",
"    Xenodiagnosis requires the availability of a laboratory-reared colony of uninfected triatomine bugs (usually Triatoma infestans or Dipetalogaster maxima) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/551/abstract/50\">",
"     50",
"    </a>",
"    ]. Bugs should be starved for at least 14 days before use. &nbsp;Direct xenodiagnosis consists of placing 5 to 10 fifth instar nymphs in a mesh box, which is then attached to the patient&rsquo;s arm or leg, and allowed to feed for 30 minutes. The process is not usually painful but often causes local irritation. Indirect xenodiagnosis consists of allowing the nymphs to feed on anticoagulated patient blood through a membrane feeding device. Direct xenodiagnosis generally has higher sensitivity, but indirect xenodiagnosis is more acceptable to patients. In either case, the triatomine nymphs are then kept for at least 28 days to allow them to pass to the adult stage. Their fecal contents are then examined for motile trypomastigotes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epimastigotes. If negative, the insects can be maintained for an additional period of time and examined at intervals for parasites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541206442\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi; the major manifestations are Chagas cardiomyopathy and gastrointestinal disease. (See",
"      <a class=\"local\" href=\"#H541206302\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Humans usually become infected when the triatomine vector defecates during its blood meal and fecal material containing the parasite is inoculated through the bite wound or mucous membranes. Transmission can also occur congenitally from mother to infant, via transfusion of blood components, via transplantation of an organ from an infected donor, and via consumption of contaminated food or drink. Individuals with chronic infection are capable of transmitting infection even in the absence of clinical manifestations. (See",
"      <a class=\"local\" href=\"#H541206318\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incubation period following exposure is one to two weeks, after which the acute phase of Chagas disease begins. In the setting of transfusion- and transplant-associated cases the incubation period may be as long as four months. The acute phase of T. cruzi infection lasts 8 to 12 weeks and is characterized by circulating trypomastigotes detectable by microscopy of fresh blood or buffy coat smears (",
"      <a class=\"graphic graphic_picture graphicRef60060 \" href=\"UTD.htm?14/16/14593\">",
"       picture 1",
"      </a>",
"      ). In general, most patients do not come to clinical attention during the acute phase. (See",
"      <a class=\"local\" href=\"#H541206326\">",
"       'Acute phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The chronic phase begins once parasitemia falls below levels detectable by microscopy (in the absence of antitrypanosomal therapy). Patients with the indeterminate form of Chagas disease have chronic T. cruzi infection with positive serology, in the absence of signs or symptoms of Chagas cardiomyopathy or gastrointestinal disease. Such patients have normal electrocardiogram findings and normal radiological examination of the chest, esophagus, and colon. (See",
"      <a class=\"local\" href=\"#H541206350\">",
"       'Chronic phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of acute infection consists of detecting motile trypomastigotes via microscopy of fresh preparations of anticoagulated blood or buffy coat. Diagnosis of chronic infection requires serological methods to detect IgG antibodies to T. cruzi. Two tests based on different antigens",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      techniques are used in parallel to increase the accuracy of the diagnosis; no available assay has sufficient sensitivity and specificity to be used alone. (See",
"      <a class=\"local\" href=\"#H541206387\">",
"       'Laboratory diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/1\">",
"      Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev 2011; 24:655.",
"     </a>",
"    </li>",
"    <li>",
"     Maguire JH. Trypanosoma. In: Infectious Diseases, 2nd ed, Gorbach S, Bartlett J, Blacklow N (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Chagas disease after organ transplantation--United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/4\">",
"      Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/5\">",
"      Acquatella H. Echocardiography in Chagas heart disease. Circulation 2007; 115:1124.",
"     </a>",
"    </li>",
"    <li>",
"     Secretaria de Vigilancia em Saude de Brasil. Doenca de Chagas Aguda. Nota Tecnica, 9 de outubro de 2007. Brasilia, Brasil, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/7\">",
"      Beltr&atilde;o Hde B, Cerroni Mde P, Freitas DR, et al. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007. Trop Doct 2009; 39:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/8\">",
"      Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis 2009; 49:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/9\">",
"      Torrico F, Alonso-Vega C, Suarez E, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004; 70:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/10\">",
"      Sosa-Estani S. [Congenital transmission of Trypanosoma cruzi infection in Argentina]. Rev Soc Bras Med Trop 2005; 38 Suppl 2:29.",
"     </a>",
"    </li>",
"    <li>",
"     Schijman AG. Congenital Chagas Disease. In: Congenital and Other Related Infectious Diseases of the Newborn, Mushahwar IK (Ed), Elsevier, Amsterdam, Netherlands 2006. Vol 13, p.223.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Congenital transmission of Chagas disease - Virginia, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/13\">",
"      S&aacute;nchez Negrette O, Mora MC, Basombr&iacute;o MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005; 115:e668.",
"     </a>",
"    </li>",
"    <li>",
"     WHO Expert Committee. Control of Chagas Disease. World Health Organization, Brasilia, Brazil 2002. p. 1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/15\">",
"      Minist&eacute;rio da Sa&uacute;de. Secretaria de Vigil&acirc;ncia em Sa&uacute;de. [Brazilian Consensus on Chagas disease]. Rev Soc Bras Med Trop 2005; 38 Suppl 3:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/16\">",
"      Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007; 298:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/17\">",
"      Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/18\">",
"      Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999; 29:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/19\">",
"      Fontes Rezende RE, Lescano MA, Zambelli Ramalho LN, et al. Reactivation of Chagas' disease in a patient with non-Hodgkin's lymphoma: gastric, oesophageal and laryngeal involvement. Trans R Soc Trop Med Hyg 2006; 100:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/20\">",
"      Kohl S, Pickering LK, Frankel LS, Yaeger RG. Reactivation of Chagas' disease during therapy of acute lymphocytic leukemia. Cancer 1982; 50:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/21\">",
"      Metze K, Lorand-Metze I, De Almeida EA, De Moraes SL. Reactivation of Chagas' myocarditis during therapy of Hodgkin's disease. Trop Geogr Med 1991; 43:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/22\">",
"      Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 2005; 36:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/23\">",
"      Bacal F, Silva CP, Bocchi EA, et al. Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 2005; 5:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/24\">",
"      Bocchi EA, Bellotti G, Mocelin AO, et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg 1996; 61:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/25\">",
"      Campos SV, Strabelli TM, Amato Neto V, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 2008; 27:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/26\">",
"      Fiorelli AI, Stolf NA, Honorato R, et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc 2005; 37:2793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/27\">",
"      Marchiori PE, Alexandre PL, Britto N, et al. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy. J Heart Lung Transplant 2007; 26:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/28\">",
"      Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007; 101:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/29\">",
"      Wegner DH, Rohwedder RW. The effect of nifurtimox in acute Chagas' infection. Arzneimittelforschung 1972; 22:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/30\">",
"      Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 2001; 14:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/31\">",
"      Schijman AG, Vigliano C, Burgos J, et al. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant 2000; 19:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/32\">",
"      Feilij H, Muller L, Gonzalez Cappa SM. Direct micromethod for diagnosis of acute and congenital Chagas' disease. J Clin Microbiol 1983; 18:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/33\">",
"      Luquetti AO, Dias JC, Prata A. [Diagnosis and treatment of congenital infection caused by Trypanosoma cruzi in Brazil]. Rev Soc Bras Med Trop 2005; 38 Suppl 2:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/34\">",
"      Duffy T, Bisio M, Altcheh J, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis 2009; 3:e419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/35\">",
"      Russomando G, de Tomassone MM, de Guillen I, et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 1998; 59:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/36\">",
"      Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop 2003; 36:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/37\">",
"      Jackson Y, Myers C, Diana A, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis 2009; 15:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/38\">",
"      Mu&ntilde;oz J, Port&uacute;s M, Corachan M, et al. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg 2007; 101:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/39\">",
"      Sosa-Estani S, Gamboa-Le&oacute;n MR, Del Cid-Lemus J, et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am J Trop Med Hyg 2008; 79:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/40\">",
"      Verani JR, Seitz A, Gilman RH, et al. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg 2009; 80:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/41\">",
"      Umezawa ES, Bastos SF, Camargo ME, et al. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 1999; 37:1554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/42\">",
"      Tarleton RL, Reithinger R, Urbina JA, et al. The challenges of Chagas Disease-- grim outlook or glimmer of hope. PLoS Med 2007; 4:e332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/43\">",
"      Silveira-Lacerda EP, Silva AG, Junior SF, et al. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004; 87:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/44\">",
"      Leiby DA, Wendel S, Takaoka DT, et al. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/45\">",
"      Junqueira AC, Chiari E, Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. Trans R Soc Trop Med Hyg 1996; 90:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/46\">",
"      Basquiera AL, Sembaj A, Aguerri AM, et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003; 89:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/47\">",
"      Wincker P, Telleria J, Bosseno MF, et al. PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997; 114 ( Pt 4):367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/48\">",
"      Hoff R, Mott KE, Silva JF, et al. Prevalence of parasitemia and seroreactivity to Trypanosoma cruzi in a rural population of Northeast Brazil. Am J Trop Med Hyg 1979; 28:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/551/abstract/49\">",
"      Sosa Estani S, Segura EL, Ruiz AM, et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998; 59:526.",
"     </a>",
"    </li>",
"    <li>",
"     Williams JE. Leishmania and Trypanosoma. In: Medical Parasitology: A Practical Approach, Gillespie SH, Hawkey PM (Eds), Oxford University Press, Oxford, UK 2009. p.151.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14005 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_551=[""].join("\n");
var outline_f0_34_551=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H541206442\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541206302\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541206310\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206318\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206326\">",
"      Acute phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206333\">",
"      Congenital Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206350\">",
"      Chronic phase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H541206357\">",
"      - Indeterminate form",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H541206364\">",
"      - Heart disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H541206372\">",
"      - Gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H541206379\">",
"      - Reactivation due to immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541206387\">",
"      LABORATORY DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206395\">",
"      Acute phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206403\">",
"      Congenital Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541206420\">",
"      Chronic phase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541206442\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/14005\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/14005|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/16/14593\" title=\"picture 1\">",
"      T cruzi trypomastigote and amastigote forms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/27/11711\" title=\"picture 2\">",
"      Trypanosomiasis Romanas sign",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=related_link\">",
"      Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23880?source=related_link\">",
"      Epidemiology and control of Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=related_link\">",
"      Gastrointestinal Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=related_link\">",
"      Treatment and prognosis of Chagas heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_552="Approach to the patient with facial erythema";
var content_f0_34_552=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with facial erythema",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/552/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/552/contributors\">",
"     Mark V Dahl, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/552/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/552/contributors\">",
"     Erik Stratman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/552/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/552/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/34/552/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 27, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H32116897\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Facial erythema (facial redness), a clinical finding most noticeable in fair-skinned individuals, occurs as a result of cutaneous blood vessel dilation and increased blood flow to the skin. Although transient facial erythema is often observed as a normal, neurologically-mediated response to strong emotion, exercise, or heat exposure, a variety of medical conditions can lead to longer-lasting and symptomatic or cosmetically distressing facial erythema.",
"   </p>",
"   <p>",
"    Examples of disorders that may present with diffuse or localized facial erythema and the evaluation of patients with this clinical finding will be reviewed here. More detailed information on flushing and many of the other disorders associated with facial erythema is available separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12857?source=see_link\">",
"     \"Approach to flushing in adults\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H72796935\">",
"     'Etiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796935\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of factors, including primary skin diseases, external insults, and systemic illness may cause facial redness. Knowledge of the distinctive characteristics of these disorders is helpful for diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796980\">",
"    <span class=\"h2\">",
"     Primary inflammatory skin diseases",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Rosacea &ndash;",
"      </strong>",
"      The erythematotelangiectatic subtype of rosacea is characterized by centrofacial erythema and telangiectasias (",
"      <a class=\"graphic graphic_picture graphicRef77020 graphicRef56083 \" href=\"UTD.htm?23/52/24391\">",
"       picture 1A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/1\">",
"       1",
"      </a>",
"      ]. Affected patients also often exhibit flushing and sensitivity of facial skin. The patient history and physical findings are usually sufficient for the diagnosis of this disorder. Other rosacea subtypes may also demonstrate these clinical features. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=see_link\">",
"       \"Rosacea: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Perioral dermatitis &ndash;",
"      </strong>",
"      Perioral dermatitis (also known as periorificial dermatitis) presents with multiple, small, inflammatory papules clustered around the mouth, nose, or eyes (",
"      <a class=\"graphic graphic_picture graphicRef73779 graphicRef64577 \" href=\"UTD.htm?5/53/5977\">",
"       picture 2A-B",
"      </a>",
"      ). Fine scale is often present. In patients with perioral lesions, the skin immediately adjacent to the vermillion border of the lip is classically spared. Perioral dermatitis most frequently affects young women; occasionally the disorder occurs in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9081?source=see_link\">",
"       \"Perioral (periorificial) dermatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Seborrheic dermatitis &ndash;",
"      </strong>",
"      Erythema accompanied by greasy scale is a characteristic feature of seborrheic dermatitis in adults. Involvement of the face typically manifests in the nasolabial folds, eyebrows, glabella, and lateral nasal areas (",
"      <a class=\"graphic graphic_picture graphicRef56410 graphicRef59104 \" href=\"UTD.htm?21/35/22070\">",
"       picture 3A-B",
"      </a>",
"      ). Other potential sites of involvement include the scalp, ears, chest, axillae, and groin. The diagnosis of seborrheic dermatitis is usually made based upon the clinical findings [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=see_link\">",
"       \"Seborrheic dermatitis in adolescents and adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Atopic dermatitis &ndash;",
"      </strong>",
"      Facial involvement of atopic dermatitis is common in infants (",
"      <a class=\"graphic graphic_picture graphicRef77386 graphicRef77457 graphicRef56461 \" href=\"UTD.htm?28/17/28953\">",
"       picture 4A-C",
"      </a>",
"      ), but may also occur in older children and adults (",
"      <a class=\"graphic graphic_picture graphicRef75681 graphicRef56815 \" href=\"UTD.htm?36/18/37161\">",
"       picture 5A-B",
"      </a>",
"      ). Intensely pruritic erythematous patches or plaques with accompanying scale, exudate, excoriations, or lichenification are often seen. The presence of a chronic, very pruritic, dermatitic skin disorder in a typical distribution suggests the possibility of atopic dermatitis [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/3\">",
"       3",
"      </a>",
"      ]. Patients may also exhibit an extra skin fold beneath the bilateral lower eyelids that is known as a Dennie-Morgan fold (",
"      <a class=\"graphic graphic_picture graphicRef62145 \" href=\"UTD.htm?19/26/19877\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Psoriasis &ndash;",
"      </strong>",
"      The clinical findings in facial psoriasis may be more subtle than the classic thick plaques with silver scale that are typical of lesions in other body areas (",
"      <a class=\"graphic graphic_picture graphicRef79191 graphicRef68576 \" href=\"UTD.htm?3/8/3210\">",
"       picture 7A-B",
"      </a>",
"      ). In some patients, lesions closely resemble the erythematous patches and fine scale of seborrheic dermatitis. The detection of lesions consistent with the classic presentation of psoriasis elsewhere on the body is helpful for diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796988\">",
"    <span class=\"h2\">",
"     Disorders due to external insults",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Irritant contact dermatitis &ndash;",
"      </strong>",
"      Contact with skin care products, cosmetics, or other substances that contain irritants may result in facial eruptions with features of eczematous dermatitis. The dermatitis may be diffuse or localized depending on the sites of contact. The facial folds and the delicate skin of the eyelids are particularly susceptible to more severe involvement.",
"      <br/>",
"      <br/>",
"      Unlike allergic contact dermatitis, which is typically associated with intense pruritus, patients with irritant contact dermatitis tend to complain of burning or prickling sensations [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/4\">",
"       4",
"      </a>",
"      ]. The patient history is critical for identifying this diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H18#H18\">",
"       \"Overview of dermatitis\", section on 'Irritant contact dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Allergic contact dermatitis &ndash;",
"      </strong>",
"      Delayed hypersensitivity reactions to external substances that contact the skin can cause acute, intense inflammatory reactions characterized by bright erythema, scale, and exudate (",
"      <a class=\"graphic graphic_picture graphicRef67215 graphicRef82705 \" href=\"UTD.htm?21/19/21818\">",
"       picture 8A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/4\">",
"       4",
"      </a>",
"      ]. Patch testing can be useful for identifying the causative antigenic substance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link\">",
"       \"Clinical features and diagnosis of allergic contact dermatitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"       \"Patch testing\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796996\">",
"    <span class=\"h2\">",
"     Photosensitive disorders",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Sunburn &ndash;",
"      </strong>",
"      The appearance of confluent, erythematous patches following sun exposure is a classic feature of sunburn (",
"      <a class=\"graphic graphic_picture graphicRef59991 \" href=\"UTD.htm?30/45/31445\">",
"       picture 9",
"      </a>",
"      ). Pruritus or pain may also be present. In severe cases, edema and blistering can occur. Desquamation commonly occurs during healing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=see_link\">",
"       \"Sunburn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Polymorphous light eruption (PMLE) &ndash;",
"      </strong>",
"      Often colloquially referred to as sun poisoning or sun allergy, PMLE may present with a wide variety of clinical manifestations [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/5\">",
"       5",
"      </a>",
"      ]. Macular erythema, papules, vesicles, or plaques may occur within hours to days after sun exposure (",
"      <a class=\"graphic graphic_picture graphicRef51455 \" href=\"UTD.htm?6/46/6882\">",
"       picture 10",
"      </a>",
"      ). PMLE is particularly likely to occur in early spring, as patient tolerance to sunlight tends to rise with increasing exposure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=see_link\">",
"       \"Polymorphous light eruption\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Phototoxic and photoallergic eruptions &ndash;",
"      </strong>",
"      Phototoxic eruptions are sunburn-like reactions induced by the ingestion or application of photosensitizing substances (",
"      <a class=\"graphic graphic_picture graphicRef69140 \" href=\"UTD.htm?34/0/34819\">",
"       picture 11",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/6\">",
"       6",
"      </a>",
"      ]. The photosensitizing agent decreases the amount of ultraviolet light exposure required to elicit this reaction. Severe eruptions with blistering and edema may occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=see_link&amp;anchor=H22#H22\">",
"       \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Phototoxicity'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Photoallergic reactions are characterized by pruritic, eczematous eruptions in sun exposed areas (",
"      <a class=\"graphic graphic_picture graphicRef63557 \" href=\"UTD.htm?7/46/7907\">",
"       picture 12",
"      </a>",
"      ). Topical, rather than ingested agents, are the most frequent causes of photoallergic reactions [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=see_link&amp;anchor=H25#H25\">",
"       \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Photoallergy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Photodamage &ndash;",
"      </strong>",
"      The formation of numerous telangiectasias secondary to chronic sun exposure is a common cause of facial redness. Sun protected areas of the face are relatively spared. Patients may have accompanying poikiloderma of Civatte, a disorder characterized by mottled pigmentation and telangiectasias on the lateral neck (",
"      <a class=\"graphic graphic_picture graphicRef81779 \" href=\"UTD.htm?32/52/33602\">",
"       picture 13",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Acute cutaneous lupus erythematosus, dermatomyositis, and lupus tumidus erythematosus",
"      </strong>",
"      (See",
"      <a class=\"local\" href=\"#H72797004\">",
"       'Systemic disorders'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H402927\">",
"       'Localized inflammatory infiltrates'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72797004\">",
"    <span class=\"h2\">",
"     Systemic disorders",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Acute cutaneous lupus erythematosus &ndash;",
"      </strong>",
"      Patients with systemic lupus erythematosus may develop acute cutaneous lupus erythematosus, which often manifests as persistent violaceous erythema on the malar area of the face (",
"      <a class=\"graphic graphic_picture graphicRef75781 graphicRef55875 \" href=\"UTD.htm?36/46/37608\">",
"       picture 14A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/8\">",
"       8",
"      </a>",
"      ]. This clinical finding is often referred to as a &ldquo;butterfly rash.&rdquo; The prominent telangiectasias of rosacea are not a feature of acute cutaneous lupus erythematosus. The presence of signs or symptoms of systemic lupus erythematosus suggests this diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=see_link&amp;anchor=H3#H3\">",
"       \"Mucocutaneous manifestations of systemic lupus erythematosus\", section on 'Acute cutaneous lupus erythematosus (butterfly rash)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=see_link\">",
"       \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Dermatomyositis &ndash;",
"      </strong>",
"      A classic sign of dermatomyositis is the &ldquo;heliotrope eruption,&rdquo; a violaceous and often edematous eruption that occurs on the eyelids and periorbital skin (",
"      <a class=\"graphic graphic_picture graphicRef56879 graphicRef68649 \" href=\"UTD.htm?14/37/14936\">",
"       picture 15A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/9\">",
"       9",
"      </a>",
"      ]. Patients may or may not have accompanying proximal muscle weakness. The detection of other cutaneous signs of dermatomyositis, such as Gottron papules and periungual telangiectasias raise suspicion for this diagnosis. In addition, the possibility of an underlying malignancy must be considered in adults with dermatomyositis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"       \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=see_link\">",
"       \"Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H402812\">",
"    <span class=\"h2\">",
"     Infectious disorders",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Viral infections &ndash;",
"      </strong>",
"      Erythema infectiosum is a viral disease caused by parvovirus B19 that most commonly occurs in children [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/10\">",
"       10",
"      </a>",
"      ]. A common feature of this disorder is the appearance of red patches on the cheeks that resemble facial skin after a slap on the face (",
"      <a class=\"graphic graphic_picture graphicRef52251 \" href=\"UTD.htm?34/20/35139\">",
"       picture 16",
"      </a>",
"      ). Nonspecific constitutional symptoms, such as fever, coryza, headache, or gastrointestinal distress usually precede the cutaneous findings. A reticulated eruption on the trunk and extremities frequently appears one to two days after the facial lesions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link&amp;anchor=H6#H6\">",
"       \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\", section on 'Erythema infectiosum'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Morbilliform or confluent facial redness may also occur as early features of other viral infections such as measles or rubella; other body sites are typically also involved (",
"      <a class=\"graphic graphic_picture graphicRef61958 graphicRef73806 \" href=\"UTD.htm?11/52/12104\">",
"       picture 17A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/11/43192?source=see_link\">",
"       \"Clinical presentation and diagnosis of measles\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26855?source=see_link\">",
"       \"Rubella\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Erysipelas &ndash;",
"      </strong>",
"      Erysipelas is a superficial form of cellulitis that usually results from infection with beta-hemolytic streptococci [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/11\">",
"       11",
"      </a>",
"      ]. Patients typically present with the acute development of an erythematous, warm, edematous, and well-defined plaque (",
"      <a class=\"graphic graphic_picture graphicRef67112 \" href=\"UTD.htm?13/19/13618\">",
"       picture 18",
"      </a>",
"      ). Fever and lymphadenopathy often accompany the cutaneous symptoms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"       \"Cellulitis and erysipelas\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H402927\">",
"    <span class=\"h2\">",
"     Localized inflammatory infiltrates",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lupus tumidus erythematosus &ndash;",
"      </strong>",
"      Also known as tumid lupus erythematosus, lupus tumidus erythematosus is an uncommon disorder that presents with erythematous plaques in sun exposed areas such as the face, neck, upper trunk, and upper extremities and scale is typically absent (",
"      <a class=\"graphic graphic_picture graphicRef71792 \" href=\"UTD.htm?13/8/13443\">",
"       picture 19",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. The vast majority of patients do not have associated systemic lupus. The performance of a biopsy assists with diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=see_link&amp;anchor=H11#H11\">",
"       \"Mucocutaneous manifestations of systemic lupus erythematosus\", section on 'Lupus erythematosus tumidus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Jessner&rsquo;s lymphocytic infiltrate &ndash;",
"      </strong>",
"      This idiopathic disorder most commonly manifests as erythematous, asymptomatic, often annular plaques on the face, neck, or upper trunk (",
"      <a class=\"graphic graphic_picture graphicRef76268 graphicRef62419 \" href=\"UTD.htm?11/40/11914\">",
"       picture 20A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. A skin biopsy is useful for diagnosis. Jessner&rsquo;s lymphocytic infiltrate shares clinical and histopathological features with lupus tumidus erythematous. The relationship between these disorders remains unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Granuloma faciale &ndash;",
"      </strong>",
"      Granuloma faciale usually presents as a solitary, red-brown, asymptomatic, round plaque with follicular prominence on the face (",
"      <a class=\"graphic graphic_picture graphicRef50769 \" href=\"UTD.htm?30/20/31046\">",
"       picture 21",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/16\">",
"       16",
"      </a>",
"      ]. The histopathologic finding of a normal-appearing thin zone in the papillary dermis (Grenz zone) above a dense inflammatory dermal infiltrate containing eosinophils, lymphocytes, neutrophils, and plasma cells is characteristic of this diagnosis. The disorder is most common in Caucasian men [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Cutaneous lymphoid hyperplasia (lymphocytoma cutis) &ndash;",
"      </strong>",
"      Cutaneous lymphoid hyperplasia occurs as a result of antigenic stimulation in the skin lading to lymphocyte proliferation. The specific cause of the disorder is often unknown, but insect bites and infections, including Lyme disease, have been linked to some cases [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. Patients typically present with a red-brown to violaceous nodule or plaque. A skin biopsy is necessary for diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical manifestations of Lyme disease in adults\", section on 'Borrelial lymphocytoma'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72797012\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Flushing &ndash;",
"      </strong>",
"      Flushing is characterized by the sudden and transient appearance of facial erythema. The etiology and clinical manifestations of flushing are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12857?source=see_link\">",
"       \"Approach to flushing in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Ruddy complexion &ndash;",
"      </strong>",
"      Generalized redness of the skin may occur as a normal feature in some individuals with fair skin (eg, Fitzpatrick skin phototype I or II (",
"      <a class=\"graphic graphic_table graphicRef60541 \" href=\"UTD.htm?15/37/15963\">",
"       table 1",
"      </a>",
"      )). Unlike erythematotelangiectatic rosacea, redness is not limited to the central face.",
"     </li>",
"     <li>",
"      <strong>",
"       Keratosis pilaris rubra &ndash;",
"      </strong>",
"      Keratosis pilaris rubra faciei is most common in children, adolescents, and young adults with fair complexions. Triangular erythematous patches are present on the bilateral cheeks (",
"      <a class=\"graphic graphic_picture graphicRef77270 \" href=\"UTD.htm?19/23/19828\">",
"       picture 22",
"      </a>",
"      ). Follicular keratotic papules are located within the areas of redness, giving the skin a rough texture [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/552/abstract/19\">",
"       19",
"      </a>",
"      ]. Clinical examination is usually sufficient for diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796943\">",
"    <span class=\"h1\">",
"     PATIENT ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step for narrowing the differential diagnosis of facial erythema is the performance of a thorough patient history and skin examination. The recognition of associated symptoms, exacerbating factors, lesion time course, and subtle clinical features of the affected area are often valuable for diagnosis. In addition, the performance of a full skin examination may yield additional skin findings that suggest an underlying cutaneous or systemic disorder.",
"   </p>",
"   <p>",
"    The clinician should consider the following points during the patient evaluation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       What are the physical characteristics of the eruption?",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Diffuse and symmetrical without scale: Ruddy complexion, flushing",
"     </li>",
"     <li>",
"      Diffuse and symmetrical with scale: Irritant contact dermatitis, airborne allergic contact dermatitis, atopic dermatitis in infants",
"     </li>",
"     <li>",
"      Symmetrical, central face or cheeks without scale: Rosacea, erythema infectiosum, keratosis pilaris rubra faciei",
"     </li>",
"     <li>",
"      Symmetrical, central face with scale: Seborrheic dermatitis, atopic dermatitis, psoriasis",
"     </li>",
"     <li>",
"      Photodistributed: Sunburn, polymorphous light eruption phototoxic reaction, photoallergic reaction, photodamage, acute cutaneous lupus erythematosus, dermatomyositis, lupus erythematosus tumidus, dermatomyositis, photoallergic reaction",
"     </li>",
"     <li>",
"      Localized plaques or patches: Erysipelas, lupus tumidus erythematosus, cutaneous lymphoid hyperplasia, Jessner&rsquo;s lymphocytic infiltrate, granuloma faciale",
"     </li>",
"     <li>",
"      Presence of telangiectasias: Photodamage, rosacea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Are there associated symptoms?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Prominent pruritus: Allergic contact dermatitis, atopic dermatitis, photoallergic reaction",
"     </li>",
"     <li>",
"      Painful or burning sensations: Sunburn, irritant contact dermatitis, phototoxicity, erysipelas, rosacea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How long has the eruption been present; how long do symptoms last?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute: Allergic contact dermatitis, atopic dermatitis flare, erythema infectiosum and other viral infections, sunburn, phototoxic reaction, photoallergic reaction",
"     </li>",
"     <li>",
"      Transient: Flushing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Has the patient applied any products to the skin that could cause an irritant or allergic reaction?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Allergic contact dermatitis, irritant contact dermatitis, photoallergic reaction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is the eruption exacerbated by sun exposure?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sunburn, phototoxic reaction, photoallergic reaction, acute cutaneous lupus erythematosus, dermatomyositis, lupus tumidus erythematosus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is the patient ingesting any photosensitizing medications or supplements?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Phototoxic reaction, occasionally photoallergic reactions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Are other body sites involved, and in what distribution?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Psoriasis, atopic dermatitis, seborrheic dermatitis, viral exanthems, drug eruptions, photodermatoses, erythroderma, other disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796957\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The workup of patients with facial redness is dependent upon the disorders suspected as a result of the clinical assessment. Diagnostic tests that can be useful for the evaluation of select patients include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Patch testing",
"      </strong>",
"     </li>",
"     <li>",
"      Skin biopsy",
"     </li>",
"     <li>",
"      Directed serologic studies (eg, investigative tests for autoimmune disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H402943\">",
"    <span class=\"h2\">",
"     Patch testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patch testing can be useful for identifying the causative allergen in patients with contact dermatitis. The procedure is most appropriate for patients in whom an allergic contact dermatitis is strongly suspected (eg, history of contact with a potential allergen, paroxysmal nature of eruptions, or severe pruritus) or in patients with persistent, pruritic, eczematous facial eruptions without another identifiable cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"     \"Patch testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The results of patch testing must be interpreted carefully since a positive patch test result does not definitively indicate that a specific allergen is the cause of dermatitis. A thorough patient interview prior to patch testing and reevaluation following the elimination of the identified allergen are essential for confirming the relevance of patch test results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H402950\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin biopsies are not necessary in most patients with facial erythema, as a thorough clinical history and skin examination often yields the diagnosis. However, in cases in which the diagnosis remains uncertain and the disorders being considered have distinctive histopathological findings, skin biopsies can be of value.",
"   </p>",
"   <p>",
"    Punch biopsies are typically performed for the evaluation of facial dermatoses as they allow for the evaluation of the full thickness of the epidermis and dermis through the removal of a relatively small skin sample. We most commonly perform 3 mm punch biopsies when evaluating inflammatory facial dermatoses. Larger punch biopsies are typically avoided to minimize scarring, and smaller biopsies may increase the risk for inconclusive histopathologic results. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=see_link&amp;anchor=H12#H12\">",
"     \"Skin biopsy techniques\", section on 'Punch biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If multiple sites are acceptable for biopsy, a site that minimizes cosmetic disfigurement should be selected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H404013\">",
"    <span class=\"h2\">",
"     Serology and other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic studies and other investigative tests may be useful in the diagnostic work-up of patients with facial redness related to systemic disorders such as acute cutaneous lupus erythematosus, dermatomyositis, or certain infections. The selection of studies is based upon the clinical suspicion for specific underlying disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3338?source=see_link\">",
"     \"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link&amp;anchor=H10#H10\">",
"     \"Systemic lupus erythematosus in children\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31079?source=see_link\">",
"     \"Diagnosis of juvenile dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H769966\">",
"    <span class=\"h1\">",
"     TOPICAL CORTICOSTEROID USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of facial erythema should be selected based upon the measures appropriate for the specific underlying disorder. For corticosteroid-responsive inflammatory dermatoses, low potency agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    1% or 2.5%) are most frequently employed to minimize risk for the induction of acneiform eruptions and cutaneous atrophy that may lead to telangiectasias and a red hue to the skin (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    With the exception of specific disorders in which higher potency topical corticosteroids are required (eg, discoid lupus erythematosus), the use of medium or high potency topical corticosteroids for inflammatory facial dermatoses generally is not recommended. Facial dermatoses requiring treatment with medium or high potency topical corticosteroids are best managed by a dermatologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H72796966\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation by a dermatologist is appropriate for patients with facial redness of unknown cause or that fails to respond as expected to therapy. Facial biopsies and patch testing are best performed by clinicians trained in these procedures. (See",
"    <a class=\"local\" href=\"#H402943\">",
"     'Patch testing'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H402950\">",
"     'Biopsy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H402961\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Facial redness is a common cutaneous finding that may occur as a normal feature or as a consequence of cutaneous or systemic disorders. Examples of conditions that may lead to facial redness include inflammatory skin disease, photosensitive disorders, autoimmune disorders, vascular reactions, and infections. (See",
"      <a class=\"local\" href=\"#H72796935\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of the patient with facial redness begins with a thorough patient history and skin examination. Details such as the features of cutaneous lesions, symptoms, duration of the eruption, and exacerbating factors should be assessed. (See",
"      <a class=\"local\" href=\"#H72796943\">",
"       'Patient assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the diagnosis of disorders of facial erythema can commonly be made based upon the patient history and clinical examination, patch testing, skin biopsy, or laboratory studies may be beneficial in select patients. Obtainment of antinuclear antibody testing is not indicated in all patients with facial redness. (See",
"      <a class=\"local\" href=\"#H72796957\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/1\">",
"      Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/2\">",
"      Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med 2009; 360:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/3\">",
"      Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/4\">",
"      Nosbaum A, Vocanson M, Rozieres A, et al. Allergic and irritant contact dermatitis. Eur J Dermatol 2009; 19:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/5\">",
"      H&ouml;nigsmann H. Polymorphous light eruption. Photodermatol Photoimmunol Photomed 2008; 24:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/6\">",
"      Millard TP, Hawk JL. Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol 2002; 3:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/7\">",
"      Gonz&aacute;lez E, Gonz&aacute;lez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/8\">",
"      Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009; 10:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/9\">",
"      Costner MI, Grau RH. Update on connective tissue diseases in dermatology. Semin Cutan Med Surg 2006; 25:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/10\">",
"      Vafaie J, Schwartz RA. Erythema infectiosum. J Cutan Med Surg 2005; 9:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/11\">",
"      Bonnetblanc JM, B&eacute;dane C. Erysipelas: recognition and management. Am J Clin Dermatol 2003; 4:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/12\">",
"      Choonhakarn C, Poonsriaram A, Chaivoramukul J. Lupus erythematosus tumidus. Int J Dermatol 2004; 43:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/13\">",
"      Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 2010; 19:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/14\">",
"      Poenitz N, Dippel E, Klemke CD, et al. Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition. Dermatology 2003; 207:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/15\">",
"      R&eacute;my-Leroux V, L&eacute;onard F, Lambert D, et al. Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: Multicenter study of 46 cases. J Am Acad Dermatol 2008; 58:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/16\">",
"      Thiyanaratnam J, Doherty SD, Krishnan B, Hsu S. Granuloma faciale: Case report and review. Dermatol Online J 2009; 15:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/17\">",
"      Colli C, Leinweber B, M&uuml;llegger R, et al. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol 2004; 31:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/18\">",
"      Mullegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004; 14:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/552/abstract/19\">",
"      Marqueling AL, Gilliam AE, Prendiville J, et al. Keratosis pilaris rubra: a common but underrecognized condition. Arch Dermatol 2006; 142:1611.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13686 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-213.131.41.98-64F77B4D5B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_552=[""].join("\n");
var outline_f0_34_552=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H402961\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32116897\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H72796935\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H72796980\">",
"      Primary inflammatory skin diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H72796988\">",
"      Disorders due to external insults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H72796996\">",
"      Photosensitive disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H72797004\">",
"      Systemic disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H402812\">",
"      Infectious disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H402927\">",
"      Localized inflammatory infiltrates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H72797012\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H72796943\">",
"      PATIENT ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H72796957\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H402943\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H402950\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H404013\">",
"      Serology and other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H769966\">",
"      TOPICAL CORTICOSTEROID USE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H72796966\">",
"      INDICATIONS FOR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H402961\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13686\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13686|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/49/37649\" title=\"picture 1A\">",
"      Rosacea erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/61/32722\" title=\"picture 1B\">",
"      Rosacea erythema cheek",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/39/22131\" title=\"picture 2A\">",
"      Perioral dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/17/8469\" title=\"picture 2B\">",
"      Perioral dermatitis lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/58/34721\" title=\"picture 3A\">",
"      Seborrheic dermatitis face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/42/28320\" title=\"picture 3B\">",
"      Seborrheic dermatitis face 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/35/37428\" title=\"picture 4A\">",
"      Atopic dermatitis infant 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/55/23408\" title=\"picture 4B\">",
"      Atopic dermatitis infantile I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/50/28448\" title=\"picture 4C\">",
"      Atopic dermatitis infantile II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/29/8662\" title=\"picture 5A\">",
"      Periocular atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/59/35764\" title=\"picture 5B\">",
"      Facial atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/26/19877\" title=\"picture 6\">",
"      Dennie-Morgan fold",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/28/14789\" title=\"picture 7A\">",
"      Facial psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/15/26870\" title=\"picture 7B\">",
"      Psoriasis on the face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/43/694\" title=\"picture 8A\">",
"      Allergic contact dermatitis face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/39/35447\" title=\"picture 8B\">",
"      Facial allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/45/31445\" title=\"picture 9\">",
"      Sunburn on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/46/6882\" title=\"picture 10\">",
"      PMLE face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/0/34819\" title=\"picture 11\">",
"      Phototoxic eruption on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/46/7907\" title=\"picture 12\">",
"      Photoallergic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/52/33602\" title=\"picture 13\">",
"      Poikiloderma of Civatte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/39/32371\" title=\"picture 14A\">",
"      Acute cutaneous lupus erythematosus - malar",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/47/3828\" title=\"picture 14B\">",
"      Acute cutaneous lupus erythematosus - malar eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/6/29793\" title=\"picture 15A\">",
"      Dermatomyositis - heliotrope eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/10/29860\" title=\"picture 15B\">",
"      Dermatomyositis - heliotrope eruption on eyelid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/20/35139\" title=\"picture 16\">",
"      Erythema infectiosum facial eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/23/33138\" title=\"picture 17A\">",
"      Measles lesions on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/43/26291\" title=\"picture 17B\">",
"      Measles facial eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/19/13618\" title=\"picture 18\">",
"      Erysipelas of the face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/8/13443\" title=\"picture 19\">",
"      Lupus erythematosus tumidus on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/61/3031\" title=\"picture 20A\">",
"      Jessner lymphocytic infiltration of the skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/53/30549\" title=\"picture 20B\">",
"      Jessner lymphocytic infiltration of the skin on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/20/31046\" title=\"picture 21\">",
"      Granuloma faciale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/23/19828\" title=\"picture 22\">",
"      Keratosis pilaris rubra faceii",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13686|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/37/15963\" title=\"table 1\">",
"      Fitzpatrick skin phototypes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 2\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12857?source=related_link\">",
"      Approach to flushing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=related_link\">",
"      Clinical features and diagnosis of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/11/43192?source=related_link\">",
"      Clinical presentation and diagnosis of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3338?source=related_link\">",
"      Diagnosis and differential diagnosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31079?source=related_link\">",
"      Diagnosis of juvenile dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=related_link\">",
"      Mucocutaneous manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=related_link\">",
"      Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=related_link\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=related_link\">",
"      Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9081?source=related_link\">",
"      Perioral (periorificial) dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=related_link\">",
"      Polymorphous light eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=related_link\">",
"      Rosacea: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26855?source=related_link\">",
"      Rubella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=related_link\">",
"      Seborrheic dermatitis in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=related_link\">",
"      Skin biopsy techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=related_link\">",
"      Sunburn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_553="Overview of benign lesions of the skin";
var content_f0_34_553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of benign lesions of the skin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/553/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/553/contributors\">",
"     Beth G Goldstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/553/contributors\">",
"     Adam O Goldstein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/553/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/553/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/553/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/553/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/34/553/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals may acquire a multitude of benign skin lesions over the course of a lifetime. Many of these lesions are easily visible, and patients often ask clinicians to confirm that new growths on the skin are benign.",
"   </p>",
"   <p>",
"    Most benign skin lesions are diagnosed on the basis of clinical appearance and history. &nbsp;If the diagnosis of a lesion is uncertain, or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis.",
"   </p>",
"   <p>",
"    Benign lesions that are symptomatic or cosmetically bothersome can often be managed with simple procedures, such as cryotherapy, electrosurgery, or excision.",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, and treatment of some common acquired skin lesions will be discussed here. Malignant neoplasms of the skin are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22009?source=see_link\">",
"     \"Pathologic characteristics of melanoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=see_link\">",
"     \"Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101419748\">",
"    <span class=\"h1\">",
"     DERMAL TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Acrochordon (skin tag)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acrochordons, commonly known as skin tags, are an outgrowth of normal skin (",
"    <a class=\"graphic graphic_picture graphicRef53025 graphicRef70871 graphicRef78524 graphicRef78625 graphicRef58450 \" href=\"UTD.htm?36/42/37546\">",
"     picture 1A-E",
"    </a>",
"    ). They appear as pedunculated lesions on narrow stalks. Skin tags occur in approximately 25 percent of adults; the risk increases with age [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a familial tendency for these lesions. Perianal skin tags are common in patients with Crohn's disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=see_link\">",
"     \"Perianal complications of Crohn's disease\"",
"    </a>",
"    .) Skin tags also appear with increased frequency during the second trimester of pregnancy and may regress postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/2\">",
"     2",
"    </a>",
"    ]. Skin tags have been reported to occur in association with colonic polyps, but these studies have predominantly been in patients with an increased incidence of polyps; studies in the primary care setting have failed to confirm such an association [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acrochordons usually occur in sites of friction, particularly the axilla, neck, inframammary, and inguinal regions. They become symptomatic when caught on jewelry or rubbed by clothing. Sometimes they become twisted on their blood supply and turn red or black (",
"    <a class=\"graphic graphic_picture graphicRef65856 \" href=\"UTD.htm?27/25/28052\">",
"     picture 1F",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis of acrochordons is based solely upon clinical appearance. They must be differentiated from the following lesions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurofibromas usually are larger and firmer than acrochordons.",
"     </li>",
"     <li>",
"      Pedunculated dermal nevus sometimes can only be differentiated histologically",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment is indicated if lesions are irritating or the patient desires removal for cosmetic reasons. Local anesthesia with 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    with epinephrine, 0.9 percent normal saline, or EMLA cream may be required in larger lesions. Treatment options include (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=see_link\">",
"     \"Dermatologic procedures\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excision with forceps or fine grade scissors; larger lesions may require suturing",
"     </li>",
"     <li>",
"      Cryosurgery with liquid nitrogen",
"     </li>",
"     <li>",
"      Electrodesiccation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lesions often bleed freely. Thus, aluminum chloride,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/53/42834?source=see_link\">",
"     silver nitrate",
"    </a>",
"    sticks, or electrosurgery should be readily available.",
"   </p>",
"   <p>",
"    Patients can expect to get new lesions in predisposed areas rather than recurrences.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101419831\">",
"    <span class=\"h2\">",
"     Dermatofibroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatofibromas represent a benign proliferation of fibroblasts that sometimes occur as a result of trauma or insect bites, but often are idiopathic. Most patients have isolated lesions, although some have up to ten at a time.",
"   </p>",
"   <p>",
"    Dermatofibromas are firm, often hyperpigmented nodules, most commonly located on the lower extremities. They occur most often in adults. The lesions are usually asymptomatic, but may be pruritic. Women with dermatofibromas on their legs commonly complain of repeated trauma when shaving their legs, and therefore may seek removal of the lesions.",
"   </p>",
"   <p>",
"    Dermatofibromas are recognized as discrete, firm lesions, 0.3 to 1.0 cm in diameter, that are nontender and that dimple when pinched together because of the fibrous nature of the lesion (",
"    <a class=\"graphic graphic_picture graphicRef80587 graphicRef68729 graphicRef80575 \" href=\"UTD.htm?32/8/32906\">",
"     picture 2A-C",
"    </a>",
"    ). Diagnosis is based upon clinical appearance. If the lesion is longstanding, it should have no history of change in appearance.",
"   </p>",
"   <p>",
"    Dermatofibromas must be differentiated from nevi. The former tend to be firmer, and nevi do not button hole or dimple when pinched.",
"   </p>",
"   <p>",
"    Dermatofibromas also must be differentiated from basal cell carcinomas. Nodular basal cells usually are waxy and have telangiectasias. Biopsy is rarely necessary to differentiate the two.",
"   </p>",
"   <p>",
"    Usually, no treatment is required unless the lesion is symptomatic, has recently changed in size or color, or is bleeding. When the lesion protrudes above the skin surface and is irritated from repeated trauma, consider partial removal with cryosurgery or shave excision. Warn patients that the lesion may recur and that the scar can look worse than the initial lesion, especially on the lower extremity. Excision with suture is indicated for any changing lesion, because rarely dermatofibromas may develop into dermatofibrosarcoma protuberans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34602?source=see_link\">",
"     \"Head and neck sarcomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420005\">",
"    <span class=\"h2\">",
"     Neurofibroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous neurofibromas are benign tumors composed of cells of neuromesenchymal origin. Although multiple neurofibromas may occur in the setting of neurofibromatosis, neurofibromas most commonly occur as sporadic, solitary lesions in healthy adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cutaneous neurofibromas typically present as asymptomatic, soft, flesh-colored or hyperpigmented papules or nodules that are less than two centimeters in diameter (",
"    <a class=\"graphic graphic_picture graphicRef82612 \" href=\"UTD.htm?8/35/8758\">",
"     picture 3",
"    </a>",
"    ). Applying direct pressure to some neurofibromas may make them seem to retract into the skin, a finding that has been described as the &ldquo;button-hole&rdquo; sign. The clinical differential diagnosis for neurofibromas often includes dermal melanocytic nevi (",
"    <a class=\"graphic graphic_picture graphicRef76961 \" href=\"UTD.htm?5/26/5540\">",
"     picture 4",
"    </a>",
"    ) and acrochorda (",
"    <a class=\"graphic graphic_picture graphicRef53025 \" href=\"UTD.htm?12/62/13282\">",
"     picture 1A",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=see_link\">",
"     \"Acquired melanocytic nevi (moles)\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H2\">",
"     'Acrochordon (skin tag)'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Treatment is not necessary for solitary cutaneous neurofibromas. Surgical excision can be used to remove lesions when the diagnosis is in question or when removal is desired due to discomfort or cosmetic concerns.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101421982\">",
"    <span class=\"h1\">",
"     EPIDERMAL TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101421989\">",
"    <span class=\"h2\">",
"     Seborrheic keratosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seborrheic keratoses are common epidermal tumors, usually developing after age 50 although occasionally in young adulthood. These lesions represent a benign proliferation of immature keratinocytes. The number of seborrheic keratoses can vary from an isolated lesion to literally hundreds present in the same person. The tendency for seborrheic keratoses may be inherited in an autosomal dominant fashion or associated with the healing phase of inflammatory skin diseases. There is no way to prevent the development of new lesions.",
"   </p>",
"   <p>",
"    The sign of Leser-Trelat, which refers to the sudden appearance of multiple seborrheic keratoses in association with skin tags and acanthosis nigricans, has been associated with a variety of malignancies, including gastrointestinal and lung cancers. The observation that both seborrheic keratoses and cancer are common in elderly individuals has caused some to question this association, although the simultaneous development of acanthosis nigricans suggests that this may be a true neoplastic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link&amp;anchor=H3208461#H3208461\">",
"     \"Cutaneous manifestations of internal malignancy\", section on 'Sign of Leser-Trelat'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link&amp;anchor=H9#H9\">",
"     \"Cutaneous manifestations of internal malignancy\", section on 'Acanthosis nigricans'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As mentioned, seborrheic keratoses are benign lesions. However, they have been reported in association with a number of other skin malignancies, most commonly basal cell carcinomas and infrequently melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis is based on the clinical appearance of &ldquo;stuck on,&rdquo; warty, well-circumscribed, often scaly hyperpigmented lesions located most commonly on the trunk, face, and upper extremities (",
"    <a class=\"graphic graphic_picture graphicRef59020 graphicRef81260 graphicRef58923 graphicRef70644 \" href=\"UTD.htm?37/38/38506\">",
"     picture 5A-D",
"    </a>",
"    ). Close inspection with a hand lens often will demonstrate the presence of horn cysts or dark keratin plugs. Lesions should almost be able to be picked off with a no. 15 blade. Biopsy may be necessary to confirm the diagnosis for atypical lesions.",
"   </p>",
"   <p>",
"    Seborrheic keratoses should be differentiated from the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nevus does not have a stuck-on or warty appearance, and there is an absence of scale.",
"     </li>",
"     <li>",
"      Melanoma does not have a stuck-on warty appearance. Look for blurring of borders, asymmetry, and a history of a changing mole.",
"     </li>",
"     <li>",
"      Pigmented basal cell carcinomas should have a history of a slowly changing lesion, along with a waxy appearance. Look for dilated blood vessels and any ulceration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dermatosis papulosa nigra is a variant of seborrheic keratosis commonly found on the faces of black patients. Lesions are small, darkly pigmented papules, which may be pedunculated (",
"    <a class=\"graphic graphic_picture graphicRef52430 \" href=\"UTD.htm?36/18/37155\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    No treatment is indicated for most seborrheic keratoses. Lesions that are symptomatic or that cause cosmetic problems can be removed. Any of the following treatments are acceptable (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=see_link\">",
"     \"Dermatologic procedures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=see_link\">",
"     \"Skin biopsy techniques\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liquid nitrogen therapy is usually successful, although thicker lesions may not respond. Hypopigmentation often occurs with healing.",
"     </li>",
"     <li>",
"      Liquid nitrogen therapy with curettage is useful for thicker lesions. Curette while the freeze ball is present.",
"     </li>",
"     <li>",
"      Snip or shave excision after anesthesia with 1 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Electrodesiccation alone or followed by curettage after anesthesia.",
"     </li>",
"     <li>",
"      Excisional biopsy with a no. 15 scalpel blade into the subcutaneous fat is indicated to rule out a melanoma or biopsy a pigmented basal cell carcinoma in any suspect lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420148\">",
"    <span class=\"h1\">",
"     APPENDAGE TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420233\">",
"    <span class=\"h2\">",
"     Pilomatricoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pilomatricoma (pilomatrixoma, calcifying epithelioma of Malherbe) is a relatively uncommon benign skin neoplasm, probably derived from matrical cells of the hair follicle. A mutation in the gene for beta-catenin, a protein involved in cell differentiation and proliferation, has been identified in some lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pilomatricomas are asymptomatic papules or nodules that most frequently occur on the head, neck, or upper extremities. They are typically firm to the touch, due to the presence of calcification within the lesions. This calcification may lead to the identification of the \"teeter-totter sign\" in larger pilomatricomas, in which depression of one side of the lesion leads to elevation of the other side [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/6\">",
"     6",
"    </a>",
"    ]. Pilomatricomas are often skin-colored, but a bluish or reddish discoloration of the overlying skin is present in some patients (",
"    <a class=\"graphic graphic_picture graphicRef81221 \" href=\"UTD.htm?8/39/8822\">",
"     picture 14D",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Pilomatricomas most commonly appear in childhood or adolescence, but may also occur in adults. They are usually solitary, but cases of multiple lesions have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/7\">",
"     7",
"    </a>",
"    ]. Multiple pilomatricomas may be familial and have been reported in association with myotonic dystrophy and other genetic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/8-15\">",
"     8-15",
"    </a>",
"    ]. Malignant transformation is rare.",
"   </p>",
"   <p>",
"    The histopathologic findings of pilomatricomas are distinctive. A well-demarcated cyst-like structure containing peripheral small, basophilic cells, and central, eosinophilic, keratinized cells is located in the lower dermis and may extend into the subcutaneous fat. The eosinophilic cells are often called \"shadow\" or \"ghost\" cells due to the absence of nuclei. Calcium deposits are present in most neoplasms; ossification may also be seen. Multinucleated giant cells are often present.",
"   </p>",
"   <p>",
"    Surgical excision is generally recommended for pilomatricomas, to prevent growth or cosmetic disfigurement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420445\">",
"    <span class=\"h2\">",
"     Epidermoid cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermoid cysts, also called epidermal cysts or epidermal inclusion cysts, are discrete nodules that often are referred to erroneously as sebaceous cysts, when in fact there is no sebaceous component. They are the most common cause of cutaneous cysts.",
"   </p>",
"   <p>",
"    The cyst wall consists of normal epidermis that produces keratin. This epidermis may have become lodged in the dermis as a result of trauma or comedone, although often there is no history of an antecedent condition. Lesions may remain stable or progressively enlarge. Spontaneous inflammation and rupture can occur, with significant involvement of surrounding tissue. There is no way to predict which lesions will remain quiescent and which will become larger or inflamed.",
"   </p>",
"   <p>",
"    Gardner's syndrome is a rare condition of multiple epidermal inclusion cysts associated with colon cancer. The syndrome is familial and inherited in an autosomal dominant fashion. Cysts are unusual in number and location (extremities rather than face, base of ears, and trunk). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=see_link\">",
"     \"Gardner syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of epidermoid cyst is based upon the clinical appearance and palpation of a discrete, freely movable cyst or nodule, often with a central punctum (",
"    <a class=\"graphic graphic_picture graphicRef55769 graphicRef50581 \" href=\"UTD.htm?2/14/2280\">",
"     picture 7A-B",
"    </a>",
"    ). These lesions are differentiated from pilar cysts, which occur on the scalp and face and are derived from hair root sheaths; they are benign lesions and can be treated in a similar fashion. Nasal gliomas are another possible confusing diagnosis; these occur at the nasal root, are often present at birth, and may communicate with brain matter. Be cautious of cyst-like structures centrally located on the scalp that have been present since birth; these may have communicating features with the central nervous system.",
"   </p>",
"   <p>",
"    Inflamed, uninfected epidermoid cysts often resolve spontaneously without therapy, although they tend to recur. Treatment is not necessary unless desired by the patient. Injection of Kenalog, 3",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    for the face and 10",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    for the trunk into the surrounding inflamed dermis can hasten the resolution of inflammation and may prevent infection and the need for incision and drainage. Only small amounts (enough to slightly distend the cyst) should be injected since injection of larger amounts can result in scarring.",
"   </p>",
"   <p>",
"    Excision is best accomplished when the lesion is not inflamed; when the cyst is acutely inflamed the cyst wall is very friable, complete excision usually is not possible, and recurrence is likely. Thus, it is reasonable to wait four to six weeks after inflammation has resolved before attempting excision. A description of cyst excision can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=see_link\">",
"     \"Dermatologic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infected, fluctuant cysts tend to be larger, more erythematous, and more painful than sterile inflamed cysts, although an intense inflammatory response to cyst rupture may also present as a fluctuant nodule. Fluctuant cysts require incision and drainage of the purulent material. Incise with a no. 11 blade and drain after anesthesia with 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    . The contents are then scraped out with a curette. We usually place an iodoform gauze wick into the cavity and leave in place for 24 hours, replacing the wick if the cyst is not draining effectively after this period of time. The wick is gradually withdrawn over a one to three week period.",
"   </p>",
"   <p>",
"    The presence of significant surrounding cellulitis or cysts that have not responded to drainage may require oral antibiotic therapy, although in most cases the lesions are sterile.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     Tetracycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    may be used for their antiinflammatory effects to reduce edema and erythema in mild to moderately inflamed lesions.",
"   </p>",
"   <p>",
"    Bacteria, if involved, include aerobes alone (most commonly Staphylococcus aureus), anaerobes alone, or a mixed infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/16\">",
"     16",
"    </a>",
"    ]. The drained contents should be sent for culture;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    is a reasonable empiric oral antibiotic choice pending culture results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420695\">",
"    <span class=\"h2\">",
"     Pilar cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pilar cysts (trichilemmal cysts) resemble epidermoid cysts as they are firm, slow growing subcutaneous nodules. However, these cysts are derived from the root sheath of the hair follicle and are most commonly located on the scalp (",
"    <a class=\"graphic graphic_picture graphicRef66512 graphicRef65892 \" href=\"UTD.htm?13/39/13945\">",
"     picture 8A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Seventy percent of patients with pilar cysts have a familial component, present after puberty, and often present with multiple nodules. The cysts can slowly enlarge up to 5 cm.",
"   </p>",
"   <p>",
"    Removal of these lesions is usually easier than removing epidermoid cysts, since the cyst wall is firm and tends not to rupture as easily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420658\">",
"    <span class=\"h1\">",
"     VASCULAR TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cherry angioma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cherry angiomas, also known as De Morgan spots, are mature capillary proliferations that are common in middle-aged and elderly patients. They usually occur as multiple lesions, most commonly on the trunk, and bleed profusely with any traumatic rupture. They are often dome-shaped, typically 0.1 to 0.4 cm in diameter, and always blanch with pressure, though some are more fibrotic and may not blanch completely (",
"    <a class=\"graphic graphic_picture graphicRef54605 graphicRef63468 \" href=\"UTD.htm?32/34/33319\">",
"     picture 9A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cherry angiomas must be differentiated from a Spitz nevus; the latter is an erythematous, isolated, dome-shaped papule or nodule that usually occurs in young children. Cherry angiomas may also be confused with amelanotic melanomas, which are usually friable lesions that may have recently changed in size or configuration.",
"   </p>",
"   <p>",
"    Treatment is only necessary for patients who are bothered by the lesions. Patients should be advised, however, that even after therapy new lesions are likely to develop and there is no known way to prevent them.",
"   </p>",
"   <p>",
"    The following modes of therapy may be used:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small lesions can be electrocauterized after anesthesia with 1 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      . Do not use lidocaine with epinephrine for small lesions because they may be obscured by the epinephrine.",
"     </li>",
"     <li>",
"      Shave excision and electrocauterization of the base is useful for larger lesions.",
"     </li>",
"     <li>",
"      Pulsed dye vascular laser therapy can be used to remove superficial lesions in isolated cases or for cosmesis, but the high cost rarely warrants this treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14616733\">",
"    <span class=\"h2\">",
"     Pyogenic granuloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pyogenic granuloma or lobular capillary hemangioma is a benign vascular tumor of the skin (",
"    <a class=\"graphic graphic_picture graphicRef52128 graphicRef52429 graphicRef60189 graphicRef67395 \" href=\"UTD.htm?35/49/36634\">",
"     picture 10A-D",
"    </a>",
"    ) or mucous membranes (",
"    <a class=\"graphic graphic_picture graphicRef66965 \" href=\"UTD.htm?19/60/20422\">",
"     picture 11",
"    </a>",
"    ) characterized by rapid growth and friable surface that bleeds profusely after minor trauma. Pyogenic granuloma occurs in patients of all ages, with a peak incidence in the second and third decade of life. The cause of this is unknown. Reported trigger factors include trauma and medications.",
"   </p>",
"   <p>",
"    Pyogenic granuloma is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29785?source=see_link\">",
"     \"Pyogenic granuloma (Lobular capillary hemangioma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420944\">",
"    <span class=\"h1\">",
"     ADIPOPCYTE TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Lipoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superficial subcutaneous lipomas are the most common benign soft-tissue neoplasms. Since superficial lipomas rarely cause symptoms, patients bring them to the attention of their providers either because they are concerned about the possibility of cancer or because of the cosmetic deformity of larger lesions.",
"   </p>",
"   <p>",
"    Lipomas are collections of mature fat cells, enclosed by thin fibrous capsules, and they can occur on any part of the body where fat cells coalesce. They are usually found superficially in the subcutaneous tissue, but can more rarely involve fascia or deeper muscular planes. The etiology of lipoma development is not well understood.",
"   </p>",
"   <p>",
"    A lipoma often looks like a small \"golf ball\" under the skin, albeit one that is soft due to the fat cells within the neoplasm (",
"    <a class=\"graphic graphic_picture graphicRef71267 \" href=\"UTD.htm?34/45/35538\">",
"     picture 12",
"    </a>",
"    ). Frequently, patients may have more than one lipoma, and occasionally they may have a genetic condition resulting in multiple lipomas (familial multiple lipomatosis). Malignant transformation of a lipoma into a liposarcoma is rare.",
"   </p>",
"   <p>",
"    The diagnosis of lipoma is usually made clinically, based on the fact that lipomas are soft, asymptomatic, and usually do not enlarge quickly. If a suspected lipoma causes symptoms (pain or restriction of movement), is rapidly enlarging, or is firm rather than soft, a biopsy is indicated.",
"   </p>",
"   <p>",
"    The treatment of a lipoma, if needed because of pain, cosmesis, or concerns over diagnosis, is surgical removal of the fat cells and fibrous capsule. Recurrence of an excised lipoma is not common.",
"   </p>",
"   <p>",
"    Side effects of surgery include scarring, seroma, and hematoma formation. In areas that are cosmetically sensitive, a surgical technique with segmental extraction and minimal surface incision may limit the scar size [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/17\">",
"     17",
"    </a>",
"    ]. Alternative treatment modalities include liposuction and injection with low concentrations of deoxycholate [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Deoxycholate injections led to improvement in an open-label study of six patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/19\">",
"     19",
"    </a>",
"    ]; however, further studies are necessary before this agent can be routinely recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6276055\">",
"    <span class=\"h2\">",
"     Angiolipoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiolipoma is a benign tumor of adipocytes typically occurring in adolescents and young adults. Angiolipoma presents as a soft subcutaneous nodule of 0.5 to 2 cm in diameter, usually located on the forearm and chest wall (",
"    <a class=\"graphic graphic_picture graphicRef67098 \" href=\"UTD.htm?25/58/26530\">",
"     picture 13",
"    </a>",
"    ). Lesions are frequently multiple and painful. Angiolipomas have been reported in HIV-infected individuals after starting antiretroviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/20\">",
"     20",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Clinically, angiolipomas closely resemble lipomas, although angiolipomas are usually painful and tender. Histology is necessary for diagnosis; it reveals a circumscribed, encapsulated tumor composed of an admixture of mature adipose cells and capillary vessels. Fibrin thrombi are typically seen. Occasionally, a predominance of blood vessels can be seen (cellular angiolipomas). The vascular proliferation component is not seen in lipomas.",
"   </p>",
"   <p>",
"    Single, painful lesions can be excised. The treatment of multiple lesions is difficult. Liposuction has been used in a few cases [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14616899\">",
"    <span class=\"h1\">",
"     GLOMUS TUMOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glomus tumor is a rare, benign neoplasm composed of cells resembling smooth cells of the normal glomus body [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/23\">",
"     23",
"    </a>",
"    ]. It is usually located in areas of the skin that are rich in glomus bodies (eg, the subungual regions of digits or the deep dermis of the palm, wrist, forearm, and foot).",
"   </p>",
"   <p>",
"    Glomus tumor presents as a pink or purple vascular papule or nodule associated with paroxysmal pain, cold sensitivity, and tenderness. Subungual glomus tumors are particularly painful. Nail dystrophy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a bluish-red flush are typically seen (",
"    <a class=\"graphic graphic_picture graphicRef51899 graphicRef61115 graphicRef72924 \" href=\"UTD.htm?19/44/20170\">",
"     picture 14A-C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis is suspected on the basis of the clinical appearance and history of paroxysmal pain and cold sensitivity. Histopathologic examination of the excised tumor is necessary to confirm the diagnosis.",
"   </p>",
"   <p>",
"    Histologically, glomus tumor is a well circumscribed dermal nodule composed of glomus cells, vasculature, and smooth muscle cells. Solid glomus tumor, with scarce vasculature and scant muscle component, is the most common variant [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/23\">",
"     23",
"    </a>",
"    ]. Less common variants include glomangioma, with prominent vascular component, and glomangiomyoma, with prominent vascular and smooth muscle components.",
"   </p>",
"   <p>",
"    Treatment is surgical excision. For subungual tumors, preoperative imaging studies with color Doppler ultrasonography and magnetic resonance may provide information on tumor size, shape, and precise anatomic location [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101421337\">",
"    <span class=\"h1\">",
"     MELANOCYTE PROLIFERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Melanocytic nevi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanocytic nevi (moles) are common neoplasms that result from the proliferation of cutaneous melanocytes. Nevi frequently present as pigmented macules, papules, or plaques, but may also be flesh-colored or pink. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=see_link\">",
"     \"Acquired melanocytic nevi (moles)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7447?source=see_link\">",
"     \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101421390\">",
"    <span class=\"h2\">",
"     Solar lentigo",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solar lentigo, most commonly known as liver spots or \"old age'' spots, is a proliferation of normal melanocytes secondary to chronic solar damage. These lesions occur most commonly in whites with fair complexion who have a history of chronic sun exposure. Hyperpigmentation may vary from light to dark brown, but is uniform within an individual lesion.",
"   </p>",
"   <p>",
"    Diagnosis is based on the clinical appearance of flat, oval, evenly pigmented macules in areas of chronic sun exposure, particularly the face, dorsa of the hands, shoulders, and back (",
"    <a class=\"graphic graphic_picture graphicRef86484 graphicRef61452 \" href=\"UTD.htm?24/49/25368\">",
"     picture 15A-B",
"    </a>",
"    ). These lesions must be differentiated from the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seborrheic keratoses &mdash; Early on, these lesions may be difficult to differentiate. Scale and palpable components are features of seborrheic keratoses.",
"     </li>",
"     <li>",
"      Lentigo maligna &mdash; Lesions have variable pigmentation, irregular borders, and a history of gradual enlargement.",
"     </li>",
"     <li>",
"      Lentigo maligna melanoma &mdash; This cancerous lesion has an irregular border, variable pigmentation, and may have a raised papule or nodule within the plaque. The history is of gradual change, usually over years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No treatment is needed unless the patient desires removal for cosmetic reasons. Liquid nitrogen applied for 5 seconds or less can be used if treatment is desired. Melanocytes are very sensitive to liquid nitrogen and are destroyed easily with small amounts and short exposure times. Lesions may heal with hypopigmentation. Any area that has changed color or developed a papular or nodular component should be biopsied. Patients should be educated on the use of sunscreens and sun protection; regular use of sunscreens prevents the development of solar lentigo although does not lead to regression of current lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/25\">",
"     25",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/59/36788?source=see_link\">",
"     Hydroquinone",
"    </a>",
"    cream 4 percent plus sun protection can lighten existing lesions. Thin seborrheic keratoses, which are sometimes mistaken for lentigines, will not respond to topical hydroquinone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SEBACEOUS HYPERPLASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sebaceous hyperplasia is a common skin condition involving hypertrophy of sebaceous glands. Lesions occur particularly on the central face of adults. Patients usually are concerned about the lesions either because of fear of skin cancer or because of cosmesis.",
"   </p>",
"   <p>",
"    The diagnosis is clinical and based upon the appearance of an isolated, yellow papule on the face of an adult and no history of recent change (",
"    <a class=\"graphic graphic_picture graphicRef57577 \" href=\"UTD.htm?33/23/34164\">",
"     picture 16",
"    </a>",
"    ). Lesions must be differentiated from basal cell carcinomas, which usually have a history of recent change in size and tend not to be yellow, and sebaceous carcinoma, a rare lesion that presents as a yellow papule which has a history of recent change in size or shape. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No treatment is necessary unless patients are worried about cancer or the lesion is cosmetically bothersome. When treatment is desired, electrosurgery can be performed by anesthetizing with 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , cauterizing using low energy levels to prevent scarring, and using a small curette or gauze to remove charred tissue. Alternatively, shave excision may be useful for isolated, large lesions or to rule out malignancy.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/39/7794?source=see_link\">",
"     Trichloroacetic acid",
"    </a>",
"    35 percent has also been used to superficially \"peel\" the lesions, although more than one application may be necessary and hypopigmentation may occur. Consider referral for carbon dioxide laser or dermabrasion for patients with diffuse lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     VENOUS LAKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous lakes are lesions of dilated capillaries on the face, lips, and ears of elderly patients. The lesions bleed easily following minor trauma.",
"   </p>",
"   <p>",
"    Diagnosis is based upon the appearance of the blue lesion in characteristic locations that disappear when compressed with a glass slide (",
"    <a class=\"graphic graphic_picture graphicRef82615 \" href=\"UTD.htm?1/12/1219\">",
"     picture 17",
"    </a>",
"    ). Venous lakes should be differentiated from blue nevi, which do not disappear with compression and do not usually appear on the face, ears, or lips. Nodular melanomas also can be confused with venous lakes, but do not disappear with compression, remaining a firm nodule.",
"   </p>",
"   <p>",
"    Electrosurgery after anesthesia with 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    can be used if the lesion causes a bleeding problem or is cosmetically unacceptable. Pulsed dye vascular laser may remove lesions without causing a scar [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/553/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1101420580\">",
"    <span class=\"h1\">",
"     CALLUSES AND CORNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calluses and corns (clavi) are among the most frequent skin conditions and, by virtue of their location on the feet, may be the source of considerable disability, discomfort, and pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Calluses are a diffuse thickening of the outermost layer of the skin, the stratum corneum, in response to repeated friction or pressure (",
"      <a class=\"graphic graphic_picture graphicRef86486 \" href=\"UTD.htm?10/18/10531\">",
"       picture 18A",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Corns develop similarly, but differ by having a central \"core'' that is hyperkeratotic and often painful (",
"      <a class=\"graphic graphic_picture graphicRef76048 graphicRef56092 \" href=\"UTD.htm?8/0/8199\">",
"       picture 19A-B",
"      </a>",
"      ). Corns typically occur at pressure points secondary to ill-fitting shoes, an underlying bony spur, or an abnormal gait.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These lesions are typically located on the plantar aspect of prominent metatarsals, between toe clefts, or on the dorsal aspect of toe joints.",
"   </p>",
"   <p>",
"    The diagnosis of calluses and corns is based upon their clinical appearance. They must be differentiated from plantar warts. After paring down, warts will have several dark specks that represent punctate capillary thromboses. Warts also disrupt normal skin markings so that the skin lines are no longer evident. Skin lines are more prominent in callosities.",
"   </p>",
"   <p>",
"    Calluses and corns are treated the same. Treatment begins with prevention. Patients should be advised to avoid ill-fitting shoes. Consider referring patients with severe recurrent problems for orthotic consultation to fit inner soles or metatarsal bars.",
"   </p>",
"   <p>",
"    The treatment of choice for calluses or corns is application of salicylic acid plasters. Salicylic acid plaster, 40 percent, is available without a prescription.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Debulk the callus or corn by paring skin with a no. 15 scalpel blade.",
"     </li>",
"     <li>",
"      Cut the plaster to the size of the lesion.",
"     </li>",
"     <li>",
"      Leave in place for 48 to 72 hours; keep dry.",
"     </li>",
"     <li>",
"      Pare down the remaining skin; replace the plaster patch and let the patient resume proper foot care. Tape can be used to keep the patch in place; the patch can be left on all day as long as it is confined to the involved site and does not slip onto unaffected areas. Patients should be advised to remove the white \"dead\" skin with a metal nail file or pumice stone each night before replacing the patch. Use of the patch should stop once the lesion has resolved.",
"     </li>",
"     <li>",
"      Follow up if lesions do not resolve within one to two weeks.",
"     </li>",
"     <li>",
"      Do NOT use plaster in patients with peripheral neuropathies. These patients may not notice pain with improper patch placement and can develop damage to normal skin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Salicylic acid 10 to 20 percent in petrolatum (available in 30 to 45 g tubes) is available by prescription and compounded by a pharmacist. This preparation may be useful for callous or corn formation that is too large for plaster use, but it is not useful for warts.",
"   </p>",
"   <p>",
"    Consider obtaining a foot x-ray to evaluate for an underlying bony abnormality in lesions that are recalcitrant or recurrent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/43/9905?source=see_link\">",
"       \"Patient information: Skin tags (acrochordon) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/51/818?source=see_link\">",
"       \"Patient information: Seborrheic keratosis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/52/834?source=see_link\">",
"       \"Patient information: Corns and calluses (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most benign skin lesions are diagnosed on the basis of clinical appearance and history. &nbsp;If the diagnosis of a lesion is uncertain, or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Benign lesions that are symptomatic or cosmetically bothersome can often be managed with simple procedures, such as cryotherapy, electrosurgery, or excision. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Benign skin lesions that occur in adults and children include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dermal tumors (acrochordon (",
"      <a class=\"graphic graphic_picture graphicRef70871 graphicRef78524 graphicRef78625 graphicRef58450 graphicRef65856 graphicRef53025 \" href=\"UTD.htm?41/30/42474\">",
"       picture 1A-F",
"      </a>",
"      ), dermatofibroma (",
"      <a class=\"graphic graphic_picture graphicRef80587 graphicRef68729 graphicRef80575 \" href=\"UTD.htm?32/8/32906\">",
"       picture 2A-C",
"      </a>",
"      ), cutaneous neurofibroma (",
"      <a class=\"graphic graphic_picture graphicRef82612 \" href=\"UTD.htm?8/35/8758\">",
"       picture 3",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Epidermal tumors (seborrheic keratosis (",
"      <a class=\"graphic graphic_picture graphicRef59020 graphicRef81260 graphicRef58923 graphicRef70644 \" href=\"UTD.htm?37/38/38506\">",
"       picture 5A-D",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Appendage tumors (pilomatricoma (",
"      <a class=\"graphic graphic_picture graphicRef81221 \" href=\"UTD.htm?8/39/8822\">",
"       picture 14D",
"      </a>",
"      ), epidermoid cyst (",
"      <a class=\"graphic graphic_picture graphicRef55769 graphicRef50581 \" href=\"UTD.htm?2/14/2280\">",
"       picture 7A-B",
"      </a>",
"      ), pilar cyst (",
"      <a class=\"graphic graphic_picture graphicRef66512 graphicRef65892 \" href=\"UTD.htm?13/39/13945\">",
"       picture 8A-B",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Vascular tumors (cherry hemangioma (",
"      <a class=\"graphic graphic_picture graphicRef54605 graphicRef63468 \" href=\"UTD.htm?32/34/33319\">",
"       picture 9A-B",
"      </a>",
"      ), pyogenic granuloma (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29785?source=see_link\">",
"       \"Pyogenic granuloma (Lobular capillary hemangioma)\"",
"      </a>",
"      .))",
"     </li>",
"     <li>",
"      Adipocyte tumors (lipoma (",
"      <a class=\"graphic graphic_picture graphicRef71267 \" href=\"UTD.htm?34/45/35538\">",
"       picture 12",
"      </a>",
"      ), angiolipoma (",
"      <a class=\"graphic graphic_picture graphicRef67098 \" href=\"UTD.htm?25/58/26530\">",
"       picture 13",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Glomus tumor (",
"      <a class=\"graphic graphic_picture graphicRef51899 graphicRef61115 graphicRef72924 graphicRef81221 \" href=\"UTD.htm?39/23/40314\">",
"       picture 14A-D",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Melanocyte proliferations (melanocytic nevi, solar lentigo (",
"      <a class=\"graphic graphic_picture graphicRef86484 graphicRef61452 \" href=\"UTD.htm?24/49/25368\">",
"       picture 15A-B",
"      </a>",
"      )) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=see_link\">",
"       \"Acquired melanocytic nevi (moles)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7447?source=see_link\">",
"       \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Proliferation of sebaceous glands (sebaceous hyperplasia (",
"      <a class=\"graphic graphic_picture graphicRef57577 \" href=\"UTD.htm?33/23/34164\">",
"       picture 16",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Vascular dilation (venous lake (",
"      <a class=\"graphic graphic_picture graphicRef82615 \" href=\"UTD.htm?1/12/1219\">",
"       picture 17",
"      </a>",
"      ))",
"     </li>",
"     <li>",
"      Hyperkeratotic reactions to chronic friction (calluses (",
"      <a class=\"graphic graphic_picture graphicRef86486 graphicRef87626 \" href=\"UTD.htm?15/18/15657\">",
"       picture 18A-B",
"      </a>",
"      ) and corns (",
"      <a class=\"graphic graphic_picture graphicRef76048 graphicRef56092 \" href=\"UTD.htm?8/0/8199\">",
"       picture 19A-B",
"      </a>",
"      ))",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/1\">",
"      Banik R, Lubach D. Skin tags: localization and frequencies according to sex and age. Dermatologica 1987; 174:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/2\">",
"      Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/3\">",
"      Gould BE, Ellison RC, Greene HL, Bernhard JD. Lack of association between skin tags and colon polyps in a primary care setting. Arch Intern Med 1988; 148:1799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/4\">",
"      Cascajo CD, Reichel M, S&aacute;nchez JL. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am J Dermatopathol 1996; 18:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/5\">",
"      Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 1999; 21:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/6\">",
"      Castelo-Soccio L, Katowitz WR, Katowitz JA, et al. Picture of the month. Eyelid pilomatricoma. Arch Pediatr Adolesc Med 2009; 163:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/7\">",
"      Julian CG, Bowers PW. A clinical review of 209 pilomatricomas. J Am Acad Dermatol 1998; 39:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/8\">",
"      Geh JL, Moss AL. Multiple pilomatrixomata and myotonic dystrophy: a familial association. Br J Plast Surg 1999; 52:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/9\">",
"      Sherrod QJ, Chiu MW, Gutierrez M. Multiple pilomatricomas: cutaneous marker for myotonic dystrophy. Dermatol Online J 2008; 14:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/10\">",
"      Barberio E, Nino M, Dente V, Delfino M. Guess what! Multiple pilomatricomas and Steiner disease. Eur J Dermatol 2002; 12:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/11\">",
"      Cambiaghi S, Ermacora E, Brusasco A, et al. Multiple pilomatricomas in Rubinstein-Taybi syndrome: a case report. Pediatr Dermatol 1994; 11:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/12\">",
"      Noguchi H, Kayashima K, Nishiyama S, Ono T. Two cases of pilomatrixoma in Turner's syndrome. Dermatology 1999; 199:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/13\">",
"      Wood S, Nguyen D, Hutton K, Dickson W. Pilomatricomas in Turner syndrome. Pediatr Dermatol 2008; 25:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/14\">",
"      Blaya B, Gonzalez-Hermosa R, Gardeazabal J, Diaz-Perez JL. Multiple pilomatricomas in association with trisomy 9. Pediatr Dermatol 2009; 26:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/15\">",
"      Pujol RM, Casanova JM, Egido R, et al. Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome? Pediatr Dermatol 1995; 12:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/16\">",
"      Brook I. Microbiology of infected epidermal cysts. Arch Dermatol 1989; 125:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/17\">",
"      Chandawarkar RY, Rodriguez P, Roussalis J, Tantri MD. Minimal-scar segmental extraction of lipomas: study of 122 consecutive procedures. Dermatol Surg 2005; 31:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/18\">",
"      Wilhelmi BJ, Blackwell SJ, Mancoll JS, Phillips LG. Another indication for liposuction: small facial lipomas. Plast Reconstr Surg 1999; 103:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/19\">",
"      Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 2005; 53:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/20\">",
"      Dank JP, Colven R. Protease inhibitor-associated angiolipomatosis. J Am Acad Dermatol 2000; 42:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/21\">",
"      Kaneko T, Tokushige H, Kimura N, et al. The treatment of multiple angiolipomas by liposuction surgery. J Dermatol Surg Oncol 1994; 20:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/22\">",
"      Kanter WR, Wolfort FG. Multiple familial angiolipomatosis: treatment of liposuction. Ann Plast Surg 1988; 20:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/23\">",
"      Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med 2008; 132:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/24\">",
"      Baek HJ, Lee SJ, Cho KH, et al. Subungual tumors: clinicopathologic correlation with US and MR imaging findings. Radiographics 2010; 30:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/25\">",
"      Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/553/abstract/26\">",
"      Jay H, Borek C. Treatment of a venous-lake angioma with intense pulsed light. Lancet 1998; 351:112.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5573 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-221.179.173.170-4115C7D097-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_553=[""].join("\n");
var outline_f0_34_553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101419748\">",
"      DERMAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Acrochordon (skin tag)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101419831\">",
"      Dermatofibroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420005\">",
"      Neurofibroma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101421982\">",
"      EPIDERMAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101421989\">",
"      Seborrheic keratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420148\">",
"      APPENDAGE TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420233\">",
"      Pilomatricoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420445\">",
"      Epidermoid cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420695\">",
"      Pilar cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420658\">",
"      VASCULAR TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cherry angioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14616733\">",
"      Pyogenic granuloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420944\">",
"      ADIPOPCYTE TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Lipoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6276055\">",
"      Angiolipoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14616899\">",
"      GLOMUS TUMOR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101421337\">",
"      MELANOCYTE PROLIFERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Melanocytic nevi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1101421390\">",
"      Solar lentigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SEBACEOUS HYPERPLASIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      VENOUS LAKE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1101420580\">",
"      CALLUSES AND CORNS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5573\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5573|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/62/13282\" title=\"picture 1A\">",
"      Acrochordon - close view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/6/22638\" title=\"picture 1B\">",
"      Skin tag",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/0/11265\" title=\"picture 1C\">",
"      Acrochordon thigh",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/29/33238\" title=\"picture 1D\">",
"      Acrochodae - axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/2/35872\" title=\"picture 1E\">",
"      Irritated skin tag",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/25/28052\" title=\"picture 1F\">",
"      Acrochordon - strangulated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/12/29892\" title=\"picture 2A\">",
"      Dermatofibroma - shin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/7/17527\" title=\"picture 2B\">",
"      Dermatofibroma - dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/36/36417\" title=\"picture 2C\">",
"      Dermatofibroma dimple",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/35/8758\" title=\"picture 3\">",
"      Cutaneous neurofibroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/26/5540\" title=\"picture 4\">",
"      Intradermal nevus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/40/16015\" title=\"picture 5A\">",
"      Seborrheic keratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/40/39557\" title=\"picture 5B\">",
"      Seborrheic keratosis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/60/963\" title=\"picture 5C\">",
"      Seborrheic keratosis 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/40/21126\" title=\"picture 5D\">",
"      Seborrheic keratosis 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/18/37155\" title=\"picture 6\">",
"      Dermatosis papulosa nigra",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/1/35857\" title=\"picture 7A\">",
"      Epidermal inclusion cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/6/40035\" title=\"picture 7B\">",
"      Epidermoid cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/14/40164\" title=\"picture 8A\">",
"      Pilar cyst 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/4/18500\" title=\"picture 8B\">",
"      Pilar cyst 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/37/3667\" title=\"picture 9A\">",
"      Cherry angiomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/55/41841\" title=\"picture 9B\">",
"      Cherry angioma2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/2/38958\" title=\"picture 10A\">",
"      Pyogenic granuloma 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/56/36742\" title=\"picture 10B\">",
"      Pyogenic granuloma collarette",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/49/37651\" title=\"picture 10C\">",
"      Pyogenic granuloma lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/19/23859\" title=\"picture 10D\">",
"      Pyogenic granuloma - chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/60/20422\" title=\"picture 11\">",
"      Pyogenic granuloma gingival mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/45/35538\" title=\"picture 12\">",
"      Lipoma trunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/58/26530\" title=\"picture 13\">",
"      Angiolipoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/34/44578\" title=\"picture 14A\">",
"      Glomus tumor nail dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/34/5667\" title=\"picture 14B\">",
"      Glomus tumor subungual 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/39/43636\" title=\"picture 14C\">",
"      Glomus tumor subungual 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/39/8822\" title=\"picture 14D\">",
"      Pilomatricoma 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/62/36836\" title=\"picture 15A\">",
"      Solar lentigo back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/10/6306\" title=\"picture 15B\">",
"      Solar lentigo hand 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/23/34164\" title=\"picture 16\">",
"      Sebaceous hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/12/1219\" title=\"picture 17\">",
"      Venous lake lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/18/10531\" title=\"picture 18A\">",
"      Callus new",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/46/44773\" title=\"picture 18B\">",
"      Callus 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/22/353\" title=\"picture 19A\">",
"      Corn - fifth toe",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/55/33650\" title=\"picture 19B\">",
"      Corn - plantar",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44056?source=related_link\">",
"      Acquired melanocytic nevi (moles)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7351?source=related_link\">",
"      Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7447?source=related_link\">",
"      Congenital melanocytic nevi and speckled lentiginous nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=related_link\">",
"      Cutaneous manifestations of internal malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31543?source=related_link\">",
"      Dermatologic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=related_link\">",
"      Gardner syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34602?source=related_link\">",
"      Head and neck sarcomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22009?source=related_link\">",
"      Pathologic characteristics of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/52/834?source=related_link\">",
"      Patient information: Corns and calluses (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/51/818?source=related_link\">",
"      Patient information: Seborrheic keratosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/43/9905?source=related_link\">",
"      Patient information: Skin tags (acrochordon) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=related_link\">",
"      Perianal complications of Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29785?source=related_link\">",
"      Pyogenic granuloma (Lobular capillary hemangioma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40264?source=related_link\">",
"      Skin biopsy techniques",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_554="Secondary prevention of cardiovascular disease in end-stage renal disease (dialysis)";
var content_f0_34_554=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Secondary prevention of cardiovascular disease in end-stage renal disease (dialysis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/554/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     Alfred K Cheung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     William L Henrich, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/554/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/34/554/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/34/554/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/34/554/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of cardiovascular disease is an important predictor of mortality in patients with end-stage renal disease, as it accounts for almost 50 percent of deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Of these, approximately 20 percent can be attributed to the consequences of coronary heart disease (CHD). Patients with varying stages of chronic kidney disease (CKD) but who are not yet dialysis-dependent also have a markedly increased risk of morbidity and mortality from CVD, including CHD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=see_link\">",
"     \"Patient survival and maintenance dialysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with established CVD have a high risk of subsequent cardiovascular events, including myocardial infarction (MI), stroke, and death from CVD. Compared with the general population, patients undergoing maintenance dialysis have a significantly increased incidence of CVD. This is due to both an increased prevalence of traditional risk factors for CVD and risk factors due to the severe loss of kidney function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29703?source=see_link\">",
"     \"Risk factors and epidemiology of coronary artery disease in end-stage renal disease (dialysis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A discussion of risk factor modification for CVD by therapeutic lifestyle changes (TLC) and drug therapies among patients undergoing maintenance dialysis will be presented in this topic review. Although many of the issues relating to coronary heart disease are presumably similar in patients with and without renal failure, this topic review will emphasize those features that distinguish the dialysis patient from those without renal dysfunction. Discussions of this issue in patients with chronic kidney disease (CKD) who are not yet on dialysis as well as those without kidney disease are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CHD RISK EQUIVALENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients without known CHD, such as those with diabetes, have a risk of subsequent cardiovascular events that is comparable to that seen in patients with established coronary disease. Such patients are regarded as having a CHD risk equivalent.",
"   </p>",
"   <p>",
"    We agree with the practice guidelines from several national organizations which recommend that chronic kidney disease (CKD), including those with end-stage renal disease, be considered a CHD risk equivalent. This is based upon evidence that renal dysfunction (even of a mild degree) is associated with an increase in CHD risk. Although the guidelines do not give a precise definition of significant renal dysfunction, it may be defined by a serum creatinine concentration that exceeds 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [133",
"    <span class=\"nowrap\">",
"     micromol/L]",
"    </span>",
"    or an estimated glomerular filtration rate that is less than 59",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m2 or significant proteinuria. Data have also emphasized the importance of proteinuria as a risk factor, independent of glomerular filtration rate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW OF SECONDARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend risk factor modification for all dialysis patients, given that CKD is a CHD risk equivalent. In patients with established CHD, these measures are referred to as \"secondary prevention,\" or prevention of complications due to established disease.",
"   </p>",
"   <p>",
"    Evidence of benefit with cardiovascular risk factor modification has largely been shown in patients without CKD. By comparison, most interventions have not been rigorously examined and very few interventions in dialysis patients have been shown to be effective. Risk factor modification for secondary prevention in dialysis patients will be reviewed here, with the evidence examining each of the possible modalities.",
"   </p>",
"   <p>",
"    Detailed discussions of each risk factor in those without renal disease and the efficacy of primary prevention of cardiovascular disease and stroke are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=see_link\">",
"     \"Overview of primary prevention of coronary heart disease and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LIPID MODIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients without kidney disease, there is a graded relationship between the serum total cholesterol concentration and coronary risk, and the absolute risk is greater in patients with previous manifestations of coronary disease. During the past two decades, many large randomized trials in patients with normal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    modestly reduced renal function have demonstrated the benefit of lipid lowering, almost entirely with statin therapy, for secondary prevention. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43626?source=see_link\">",
"     \"Clinical trials of cholesterol lowering in patients with coronary heart disease or coronary risk equivalents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two large, well-designed trials, 4-D and AURORA, evaluated the effect of statin therapy in dialysis patients on the combined end point of death from cardiovascular causes, nonfatal myocardial infarction, and stroke. Despite a substantial decrease in serum LDL-cholesterol levels, both trials found that the initiation of statin therapy provided NO cardiovascular benefit. In apparent contrast, the SHARP trial showed a benefit of pharmacological therapy using the combination of statin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     ezetimibe",
"    </a>",
"    in the entire study cohort that included non-dialysis CKD and dialysis patients, but the effect was not statistically significant in the dialysis subgroup. [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/5\">",
"     5",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Trials of statin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issue of whether statins are effective in lowering the risk of a cardiovascular event in dialysis patients was addressed in the 4-D, AURORA and SHARP trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     4-D trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 4-D (Die Deutsche Diabetes Dialyse) study, 1255 hemodialysis patients (80 percent were not being treated with a statin) with type 2 diabetes and elevated serum LDL cholesterol levels were randomly assigned to placebo or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    (20",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/1\">",
"     1",
"    </a>",
"    ]. The primary outcome measure was the composite of cardiovascular death, nonfatal myocardial infarction, and stroke. After four weeks, atorvastatin successfully lowered LDL cholesterol (121 to 72",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.1 to 1.9",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    versus no change with placebo (125 to 120",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.2 to 3.1",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"   </p>",
"   <p>",
"    At",
"    a median follow-up of four years, there was no difference in the incidence of the primary outcome between both groups (relative risk 0.92, 95% CI 0.77-1.10). There was, however, a significant reduction in the rate of cardiac events (RR 0.82, 95% CI 0.68-0.99). On the other hand, there was a significant increase in the rate of fatal stroke (RR 2.03, 95% CI 1.05-3.93), but the absolute number of events was small in both the statin and the placebo groups.",
"    <br/>",
"    <br/>",
"    A post hoc analysis that stratified patients by LDL concentration demonstrated a reduction in the primary outcome among those with a baseline LDL concentration greater than 145",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.76",
"    <span class=\"nowrap\">",
"     mmol/L]",
"    </span>",
"    (HR 0.69, 95% CI 0.48-1.00) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/6\">",
"     6",
"    </a>",
"    ]. Among such patients there were also reductions in risk for cardiac death, sudden cardiac death, nonfatal myocardial infarction, and for all cardiac deaths combined. There was no difference between groups among patients with baseline LDL less than 145",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    Importantly, this analysis is of a subgroup that was not predefined which limits its interpretation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     AURORA trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the AURORA trial, 2776 hemodialysis patients who were not being treated with a statin were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10424?source=see_link\">",
"     rosuvastatin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/7\">",
"     7",
"    </a>",
"    ]. At three months, mean serum LDL levels were lowered significantly with rosuvastatin (100 to 58",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.6 to 1.5",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    versus no change with placebo (99 to 98",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.56 to 2.53",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"   </p>",
"   <p>",
"    At",
"    a median follow-up period of 3.8 years, the incidence of the primary composite end point (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) was similar in the two groups (9.2 versus 9.5 events per 100 patient years, hazard ratio 0.96, 95% CI 0.84-1.11). The individual components of the primary composite endpoint as well as all-cause mortality were also not significantly different between the two groups. Active therapy did not provide benefit for any analyzed prespecified subgroup, including those with diabetes or elevated C-reactive protein levels.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10424?source=see_link\">",
"     Rosuvastatin",
"    </a>",
"    was not associated with an increased incidence of adverse events.",
"   </p>",
"   <p>",
"    A post hoc analysis of 731 diabetic patients from AURORA also showed no difference in the composite outcome or in the risk of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/8\">",
"     8",
"    </a>",
"    ]. However, there was a 32 percent reduction in cardiac events (including cardiac death and nonfatal myocardial infarction) among diabetic patients assigned to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10424?source=see_link\">",
"     rosuvastatin",
"    </a>",
"    (n = 388) compared to placebo (n = 343) (HR 1.68, 95% CI 0.51-0.90) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/8\">",
"     8",
"    </a>",
"    ]. The rosuvastatin group had a higher incidence of hemorrhagic stroke compared to placebo, although the number of events was small (12 versus 2, respectively). Similar to the 4-D study, these data suggest a possible benefit of statins in the reduction of cardiac events among diabetic patients who are on dialysis although this is only a subgroup analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23811909\">",
"    <span class=\"h3\">",
"     SHARP trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The SHARP trial evaluated the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     ezetimibe",
"    </a>",
"    compared with placebo in lowering cardiovascular morbidity in patients with CKD, approximately one-third of whom required maintenance dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/5\">",
"     5",
"    </a>",
"    ]. The results dealing with the patients with CKD who were not on dialysis are discussed elsewhere. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Trials of statin therapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6248?source=see_link&amp;anchor=H8853471#H8853471\">",
"     \"Lipid abnormalities in patients with chronic kidney disease not requiring dialysis\", section on 'SHARP trial'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Originally, patients were randomly allocated to three treatment arms: a combination pill containing 20 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    and 10 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     ezetimibe",
"    </a>",
"    ; 20 mg of simvastatin only; or placebo. After one year of follow-up, however, the patients in the simvastatin-only arm were reassigned to receive either the combination pill or placebo; this re-randomization of the simvastatin-only group was prespecified to occur at one year if adverse events were no greater with the combination of simvastatin and ezetimibe than with simvastatin alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=see_link&amp;anchor=H9#H9\">",
"     \"Lipid lowering with drugs other than statins and fibrates\", section on 'Ezetimibe'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    SHARP included 3023 patients treated with maintenance dialysis. By design, none had a history of myocardial infarction or coronary revascularization. During a median follow-up of 4.9 years, the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     ezetimibe",
"    </a>",
"    was associated with a trend toward benefit in lowering the incidence of the atherosclerotic cardiovascular events (15.0 versus 16.5 percent, [RR 0.90 95% CI, 0.75-1.08]). However, the trial was not powered to detect an effect specifically in the dialysis population. Results for the individual components of this composite endpoint were presented only for the entire study population (combining dialysis and non-dialysis patients) and are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6248?source=see_link&amp;anchor=H8853471#H8853471\">",
"     \"Lipid abnormalities in patients with chronic kidney disease not requiring dialysis\", section on 'SHARP trial'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H878000148\">",
"    <span class=\"h3\">",
"     Meta-analyses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two meta-analyses have been performed of randomized controlled trials that examined a benefit of lipid-lowering agents (including statins and statins plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     ezetimibe",
"    </a>",
"    ) among patients with all stages of CKD, including those on dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one meta-analysis, subgroup analyses of patients on dialysis showed reductions in the risk of cardiac mortality (two studies, n = 1986, RR. 0.78, 95% CI 0.68&ndash;0.89), and myocardial infarction (one study, n = 731, RR 0.72, 95% CI 0.56-0.92) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/10\">",
"       10",
"      </a>",
"      ]. Analysis of two studies showed an increase in the risk of stroke (n = 1986, RR 1.47, 95% CI 1.09&ndash;2.0); however the studies that were included in this last analysis were considered of poor quality.",
"     </li>",
"     <li>",
"      Another meta-analysis had moderate to high quality evidence that, among patients on dialysis, statin treatment had little or no effect on all-cause mortality (RR 0.96, 95% CI 0.88-1.04), cardiovascular mortality (RR 0.94, 95% CI 0.82-1.07), and major cardiovascular events (RR 0.95, 95% CI 0.87-1.03). The effects of treatment on myocardial infarction and stroke were uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The results of these meta-analyses among CKD patients who are not receiving dialysis and among transplant recipients are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6248?source=see_link&amp;anchor=H877999749#H877999749\">",
"     \"Lipid abnormalities in patients with chronic kidney disease not requiring dialysis\", section on 'Meta-analyses'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29546?source=see_link&amp;anchor=H10#H10\">",
"     \"Lipid abnormalities after renal transplantation\", section on 'Treatment of dyslipidemias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite significant reductions in mean serum LDL levels, the 4-D, AURORA and SHARP trials found no definite clinical benefit with statin therapy in hemodialysis patients. However, SHARP showed a trend towards benefit specifically in atherosclerotic events, and post hoc analyses of AURORA and 4-D showed benefits among diabetic patients and among those with an LDL concentration greater than 145",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.76",
"    <span class=\"nowrap\">",
"     mmol/L],",
"    </span>",
"    respectively. In addition, one meta-analysis including all three trials showed a modest benefit in atherosclerotic-related events while another found no benefit of statin treatment in all-cause mortality, CV mortality, major CV events",
"   </p>",
"   <p>",
"    By comparison, randomized prospective studies have reported consistent and robust improvements in cardiovascular outcomes with statin therapy in patients with normal kidney function at increased risk of adverse cardiovascular events. In addition, meta-analyses and post-hoc analyses of studies of patients with mild to moderate renal dysfunction have noted benefits with statin therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most likely explanation for these discordant results is that the pathogenic processes for adverse cardiovascular outcomes among patients with end-stage renal disease differ from those with either mild to moderate renal dysfunction or normal kidney function. In the dialysis population, approximately 60 percent of all cardiac deaths are presumably due to sudden death or arrhythmias and the underlying diseases that trigger the sudden death or arrhythmias are unclear. There is a markedly increased prevalence of myocardial abnormalities, such as left ventricular hypertrophy (present in approximately 75 percent of dialysis patients) and alterations in myocardial ultrastructure and function; atheromatous coronary lesions are thought by some investigators to be less important than the nonatherosclerotic diseases, such as nonischemic cardiac fibrosis, in maintenance dialysis patients. The supportive data for these conclusions are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11288?source=see_link\">",
"     \"Evaluation of sudden cardiac arrest and sudden cardiac death in dialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We therefore recommend NOT routinely initiating statin therapy in dialysis patients despite being at high overall cardiovascular risk. The question of whether to withdraw statin therapy in dialysis patients already being treated has not been addressed in randomized trials. Both 4-D and AURORA trials had a large number of patients who discontinued the study medication, but this was most commonly due to achieving a study end point or undergoing kidney transplantation. We suggest continuing statin therapy, especially in those patients with significantly elevated serum levels of LDL-cholesterol, largely due to the overwhelming evidence of benefit in the general population. However, some clinicians would withdraw statin therapy in dialysis patients based upon the lack of benefit in 4-D and AURORA. If statin therapy is administered to dialysis patients, the following goals are reasonable, although they have not been validated in dialysis patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A serum LDL-cholesterol of less than 100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (&lt;2.6",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"     <li>",
"      A non-HDL cholesterol concentration (ie, total minus HDL cholesterol) of less than 130",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (&lt;3.36",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      in patients who have already achieved the target LDL cholesterol level but have fasting triglycerides &ge;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (&ge;2.26",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The overall recommendation not to routinely administer statins to dialysis patients does not necessarily apply to those with very high serum LDL-cholesterol levels (such as &gt;145",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.8",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    as the post-hoc analysis of the 4-D trial showed an apparent beneficial effect in patients in that subgroup. This uncertainty is particularly poignant for patients with very high LDL-cholesterol (eg, over 190",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.9",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    since those patients might not have been enrolled in AURORA because of the potential reluctance of nephrologists to refer these patients to the randomized trial. Thus, in the uncommon dialysis patient with very high cholesterol levels, it is reasonable to administer statin therapy.",
"   </p>",
"   <p>",
"    The results from 4-D, AURORA and SHARP should also not be extrapolated to patients with mild to moderate chronic kidney disease (CKD). As noted above, statin therapy is recommended given that meta-analyses and post-hoc analyses of randomized trials have reported decreased all-cause and cardiovascular mortality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"     \"Chronic kidney disease and coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30824?source=see_link\">",
"     \"Statins and chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hypertriglyceridemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertriglyceridemia is the most common lipid disturbance in dialysis patients and is attributed to the retention of putatively atherogenic particles, such as lipoprotein remnants, in the plasma. Hypertriglyceridemia is not usually treated with pharmacological therapy in dialysis patients, although whether this practice is justified for secondary cardiovascular prevention is unclear. Drug therapy in patients without renal failure for cardiovascular protection may be beneficial in selected patients with isolated hypertriglyceridemia who have proven coronary disease, a strong family history of CHD, or multiple coexisting cardiac risk factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=see_link&amp;anchor=H723637365#H723637365\">",
"     \"Approach to the patient with hypertriglyceridemia\", section on 'Mild to moderate hypertriglyceridemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether this approach is beneficial in dialysis patients is not known, but it should be considered. For those with fasting triglycerides &ge;500",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (&ge;5.65",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    that cannot be corrected by removing an underlying cause, treatment with lifestyle changes without causing malnutrition and a triglyceride-lowering agent should be considered. This indication is principally to prevent pancreatitis rather than any benefits in secondary prevention for cardiovascular events.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    clinical practice guidelines for managing dyslipidemias in CKD, as well as other",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines, can be accessed through the National Kidney Foundation's web site at",
"    <a class=\"external\" href=\"file://www.kidney.org/professionals/kdoqi/guidelines.cfm\">",
"     www.kidney.org/professionals/kdoqi/guidelines.cfm",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HYPERTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the relationship between hypertension and cardiovascular mortality in patients with end-stage renal disease is complicated, improved cardiovascular has been associated with blood pressure control in observational studies with the long duration of follow-up. However, no large randomized trials have examined this issue.",
"   </p>",
"   <p>",
"    Absent randomized trial results, the targeting of exact blood pressure goals (whether to a specific level or below a certain value) should be set individually based upon the patient's cardiac and neurologic status, comorbid conditions, age, intradialytic hemodynamics, and other clinical factors. For some hemodialysis patients, the goal BP is a predialysis value of below",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    on minimal medications, if possible. If clinical characteristics permit, a lower BP, defined as a mean ambulatory BP",
"    <span class=\"nowrap\">",
"     &lt;135/85",
"    </span>",
"    mmHg during the day and",
"    <span class=\"nowrap\">",
"     &lt;120/80",
"    </span>",
"    mmHg by night, is a reasonable target goal. However, this may not be possible in some patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20202?source=see_link\">",
"     \"Hypertension in dialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TRADITIONAL DRUG THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    therapy decreases the risk of myocardial infarction, stroke, and cardiovascular death among those with prior manifestations of CVD. The evidence concerning these issues is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a paucity of data concerning the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    in dialysis patients. Some larger observational studies have suggested that aspirin use may be associated with increased cardiovascular mortality or adverse cardiovascular events [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In one study of 28,320 patients randomly selected from the Dialysis Outcomes and Practice Patterns Study (DOPPS), aspirin was associated with an increased risk of myocardial infarction (RR 1.21, 95% CI 1.06-1.38) and any cardiac event (RR 1.08, 95% CI 1.02-1.14) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/12\">",
"     12",
"    </a>",
"    ]. In contrast, the risk of stroke was decreased with aspirin (RR 0.82, 95% CI 0.69-0.98). Similarly, an observational study of 41,425 hemodialysis patients reported that aspirin was associated with an increased risk of mortality (HR 1.06, 95% CI 1.01-1.11) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/13\">",
"     13",
"    </a>",
"    ]. In these studies, confounding by indication is difficult to rule out.",
"   </p>",
"   <p>",
"    A Cochrane meta-analysis that included randomized trials of nondialysis CKD and ESRD patients found that antiplatelet agents compared with no treatment or placebo reduced the risk of myocardial infarction (17 studies, relative risk [RR] 0.87, 95% CI 0.76- .99) but not all-cause mortality (30 studies, RR 0.93, 95% CI 0.8-1.06), cardiovascular mortality (19 studies, RR 0.89, 95% CI 0.70-1.12) or stroke (11 studies, RR 1.00, 95% CI 0.58-1.72) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/15\">",
"     15",
"    </a>",
"    ]. Antiplatelet agents increased the risk of major (27 studies, RR 1.33, 95% CI 1.10-1.65) and minor bleeding (18 studies, RR 1.49, 95% CI 1.12-1.97).",
"   </p>",
"   <p>",
"    In subgroup analysis, the relative risk of myocardial infarction among 2929 dialysis patients who received antiplatelet agents was 0.82 (95% CI 0.47-1.42), and of mortality among 4363 dialysis patients who received antiplatelet agents was 0.82 (95% CI 0.63-1.06). The relative risk of major bleeding among dialysis patients was 0.93 (13 studies, 95% CI 0.55-1.57).",
"   </p>",
"   <p>",
"    We suggest that individual treatment decisions be based upon consideration of patients' individual risks, potential benefits, and preferences. The prescription of low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (81",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is probably safe in most patients with CKD and those on chronic dialysis. These recommendations are consistent with the",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    clinical practice guidelines. However, the avoidance of aspirin in dialysis patients is also reasonable given the increased risk of bleeding and unproven cardiovascular benefit.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    clinical practice guidelines for controlling the epidemic of CV disease in CRD, as well as other",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines, can be accessed through the National Kidney Foundation's web site at",
"    <a class=\"external\" href=\"file://www.kidney.org/professionals/kdoqi/guidelines.cfm\">",
"     www.kidney.org/professionals/kdoqi/guidelines.cfm",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, beta blockers, unless contraindicated, should be part of routine therapy in patients with an acute myocardial infarction (MI) or heart failure due to systolic dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/53/11098?source=see_link\">",
"     \"Beta blockers in the management of acute coronary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12905?source=see_link\">",
"     \"Use of beta blockers in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues surrounding the use of beta blockers for secondary prevention in dialysis patients with an acute MI or heart failure are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15945?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment and prevention of sudden cardiac arrest in dialysis patients\", section on 'Heart failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15945?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment and prevention of sudden cardiac arrest in dialysis patients\", section on 'Post-myocardial infarction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link&amp;anchor=H10#H10\">",
"     \"Myocardial dysfunction in end-stage renal disease\", section on 'Therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     ACE inhibitors or ARBs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among those with normal renal function, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) decrease cardiovascular mortality in post MI patients with systolic dysfunction. In addition, ACE inhibitors provide cardiovascular benefit in most patients with an acute anterior myocardial infarction. The evidence supporting these conclusions in non-dialysis patients is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13175?source=see_link\">",
"     \"Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=see_link\">",
"     \"ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a paucity of evidence concerning the cardiovascular benefits of ACE inhibitors and ARBs in dialysis patients. Their use in these patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9416?source=see_link&amp;anchor=H5#H5\">",
"     \"Therapy of heart failure in hemodialysis patients\", section on 'Pharmacologic therapy for systolic dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many retrospective population-based studies in a very large number of hemodialysis patients and some prospective studies have explored outcomes associated with various Hgb or Hct levels. Although there is some variability in results among studies, the most consistent observation has been that better outcomes without an increase in adverse reactions are associated with Hgb values that are approximately between 10 and 12",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (hematocrit of 30 to 36 percent) compared to values below this level. This benefit applies to hemodialysis, peritoneal dialysis, and predialysis patients.",
"   </p>",
"   <p>",
"    In patients undergoing maintenance dialysis, the clinical benefits and adverse effects associated with attaining normal or near-normal hemoglobin values, compared with lower levels, have been evaluated in multiple randomized trials, meta-analyses, and systematic reviews. Evaluated outcomes have included overall mortality, cardiovascular mortality, and morbidity due to cardiovascular and cerebrovascular disease. These data and recommendations for treatment of dialysis patients with erythropoietic agents are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=see_link\">",
"     \"Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MINERAL METABOLISM ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular disease in dialysis patients may be due in part to the presence of vascular calcification, particularly in the form of extensive coronary artery calcification. A key question is what drives the development and maintenance, or progression, of such abnormal calcification. Abnormalities of mineral metabolism and therapeutic maneuvers aimed at correcting these abnormalities have been implicated as primary underlying pathogenic factors. These include hyperphosphatemia, administration of calcium-containing oral phosphate binders, elevated parathyroid hormone levels, and possibly decreased serum vitamin D levels.",
"   </p>",
"   <p>",
"    No prospective randomized studies have definitively demonstrated a cardiovascular benefit",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a survival advantage with any of the current therapeutic options, including limiting calcium intake, use of non-calcium or calcium-containing phosphate binders, active vitamin D therapy, and administration of calcimimetics. However, observational studies have shown improved survival in hemodialysis patients treated with active vitamin D analogues.",
"   </p>",
"   <p>",
"    Despite the absence of evidence from randomized trials, we generally aim for a calcium x phosphate product less than 55",
"    <span class=\"nowrap\">",
"     mg2/dL2",
"    </span>",
"    using current therapeutic options. However, it is possible that even lower levels (&lt;50",
"    <span class=\"nowrap\">",
"     mg2/dL2)",
"    </span>",
"    offer further survival advantage.",
"   </p>",
"   <p>",
"    These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=see_link\">",
"     \"Treatment of hyperphosphatemia in chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17738?source=see_link\">",
"     \"Vascular calcification in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     GLYCEMIC CONTROL IN DIABETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are cardiovascular benefits of glycemic control in patients with type 1 and type 2 diabetes who are not on dialysis. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/34/11817?source=see_link&amp;anchor=H12#H12\">",
"     \"Glycemic control and vascular complications in type 1 diabetes mellitus\", section on 'Macrovascular disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7578?source=see_link\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hemoglobin A1C target that is associated with the best clinical outcome in dialysis patients with diabetes has not been established. This issue can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7865?source=see_link\">",
"     \"Management of hyperglycemia in diabetics with end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     HYPERHOMOCYSTEINEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with normal renal function, there is an increased risk of developing CHD in those with elevated homocysteine levels. Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    lowers homocysteine levels, evidence from randomized trials does not support its use in secondary prevention in the non-dialysis population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of homocysteine\", section on 'Secondary prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperhomocysteinemia is common in patients with end-stage renal disease. As observed in those with normal kidney function, lowering homocysteine levels does not improve cardiovascular outcomes in dialysis patients. This was best shown in the double-blind randomized controlled trial Homocysteinemia in Kidney and End Stage Renal Disease (HOST), which compared the effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    pyridoxine (100",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    and vitamin B12 (2",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    versus placebo on vascular outcomes in 2056 patients with advanced chronic kidney disease (CKD), including ESRD [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/16\">",
"     16",
"    </a>",
"    ]. At a median follow-up of 3.2 years, there was NO difference between the groups in terms of total mortality, myocardial infarction, stroke, and amputations.",
"   </p>",
"   <p>",
"    Therefore, we do not administer",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    , vitamin B6,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vitamin B12 for the purpose of lowering homocysteine levels and improving cardiovascular outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DECREASED OXIDATIVE STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients without renal failure, lipid peroxidation of membrane polyunsaturated fatty acids by reactive oxygen species, which are increased during ischemia, is considered the major mechanism of ischemia-reperfusion injury. Although it had been hoped that antioxidant treatment would prevent or retard atherosclerosis, randomized evidence has NOT convincingly demonstrated clinical benefits with antioxidant vitamins. A detailed discussion of this issue in patients with normal renal function is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=see_link\">",
"     \"Nutritional antioxidants in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of studies have demonstrated that hemodialysis patients are, in general, at a state of increased oxidative stress, suggesting the possibility that antioxidant therapies may improve clinical outcomes. Limited evidence suggests that an attempt to lower oxidative stress may improve cardiovascular disease outcomes in end-stage renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one trial, 196 dialysis patients with known heart disease were randomly assigned to 800 international",
"      <span class=\"nowrap\">",
"       units/day",
"      </span>",
"      of vitamin E or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/17\">",
"       17",
"      </a>",
"      ]. At follow-up at a median of 519 days, the incidence of a primary end point (which consisted of myocardial infarction, ischemic stroke, peripheral vascular disease, and unstable angina) was significantly lower in the active therapy group (16 versus 33 percent).",
"     </li>",
"     <li>",
"      In a second randomized placebo-controlled trial of 134 patients, the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=see_link\">",
"       acetylcysteine",
"      </a>",
"      (600 mg two times per day) was associated with a decrease in total and cardiovascular mortality at a median follow-up of 14 months (RR 0.60, 95% CI of 0.38-0.95) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Large randomized trials on the effect of antioxidant therapy on clinical outcomes in dialysis patients are lacking.",
"   </p>",
"   <p>",
"    Another strategy to attempt to lower oxidative stress is hemodialysis with vitamin E-bonded dialysis membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. With this technique, vitamin E is incorporated by coating a cellulose-based membrane with alpha-tocopherol. A number of studies have found that the use of such membranes is associated with subclinical improvements, such as better endothelial dysfunction. In the only trial with clinical outcomes thus far, regression of carotid intimal thickness was noted in those exposed to vitamin-E coated dialyzers [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/22\">",
"     22",
"    </a>",
"    ]. Further studies are needed to better understand the role for these dialyzers.",
"   </p>",
"   <p>",
"    Pending further evidence of clinical benefit, we do not currently prescribe any agent with the aim of lowering oxidative stress and improving cardiovascular outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     FISH OIL",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the general population, evidence from observational studies suggests that dietary fatty fish intake and fish oil supplementation are associated with a lower cardiac mortality. Based upon these results, subsequent randomized trials have evaluated the benefit of fish oil supplements containing omega-3 fatty acids in various high-risk populations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one randomized placebo-controlled study of the effects of omega-3 fatty acids for secondary prevention, among 206 patients, no significant effect on the primary outcome of cardiovascular events and death was observed with omega-3 fatty acids [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/23\">",
"     23",
"    </a>",
"    ]. However, a significantly smaller number of myocardial infarctions, a secondary outcome, occurred with active therapy (4 versus 13 in the placebo group).",
"   </p>",
"   <p>",
"    In another randomized multicenter trial in which the effect of fish oil on arteriovenous (AV) graft thrombosis as the primary outcome was assessed among 201 patients, fish oil was associated with a better cardiovascular event-free survival (hazard ratio, 0.43 [95% CI, 0.19-0.96]) and lower mean systolic blood pressure (-3.61 vs 4.49 mm Hg) at 12 months of followup [",
"    <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/24\">",
"     24",
"    </a>",
"    ]. The effect of fish oil on graft thrombosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7942?source=see_link&amp;anchor=H7#H7\">",
"     \"Strategies other than treatment of stenosis to prevent thrombosis of hemodialysis vascular access grafts\", section on 'Fish oil'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ability of this approach to prevent coronary events in patients with ESRD requires further study, particularly in larger trials.",
"   </p>",
"   <p>",
"    At present, we do not administer fish oil for cardiovascular protection in dialysis patients. The role of fish oil for prevention of AV graft thrombosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7942?source=see_link&amp;anchor=H7#H7\">",
"     \"Strategies other than treatment of stenosis to prevent thrombosis of hemodialysis vascular access grafts\", section on 'Fish oil'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     THERAPEUTIC LIFESTYLE CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic lifestyle changes are a part of decreasing the risk of adverse cardiovascular outcomes in dialysis patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking &mdash; In hemodialysis patients, smoking greatly increases the risk for cardiovascular morbidity and mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]. However, unlike that found in the general population, there are few studies showing beneficial cardiovascular outcomes with smoking cessation in dialysis patients. In a post hoc analysis of the HEMO study including 1842 hemodialysis patients, there was a trend toward an increase in risk of cardiovascular mortality among current smokers compared with former smokers but this was not statistically significant [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/27\">",
"       27",
"      </a>",
"      ]. In this analysis, the population attributable fractions, (ie, the fraction of observed deaths that may have been avoided), were 5.3 for current smokers versus patients who never smoked and 2.1 for current versus former smokers. We recommend that dialysis patients completely stop smoking, given the marked benefits of smoking cessation observed in the general population. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=see_link\">",
"       \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Weight reduction &mdash; In those with normal renal function, obesity is associated with an increased risk for cardiovascular disease. By comparison, the benefits of weight reduction in dialysis patients are unclear. In fact, there appears to be a survival advantage in obese dialysis patients. The higher mortality risks in dialysis patients with lower body mass indices may be attributed to malnutrition. Limited data suggest that increased muscle mass confers greater survival advantage than increased fat in the dialysis population [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/28\">",
"       28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In general, we do not currently recommend weight reduction for dialysis patients, although it is reasonable to recommend an increase in muscle rather than fat. Weight reduction, however, should be considered in morbidly obese patients, especially in those who are planning kidney transplant surgery.",
"     </li>",
"     <li>",
"      Exercise &mdash; Regular exercise has a variety of possible cardiovascular benefits in those with normal renal function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"       \"Exercise and fitness in the prevention of cardiovascular disease\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      By comparison, a paucity of data exists concerning the association between cardiovascular benefits, survival, and exercise in dialysis patients. This was examined using data for 2507 patients from the Dialysis Morbidity and Mortality Wave 2 study [",
"      <a class=\"abstract\" href=\"UTD.htm?0/34/554/abstract/29\">",
"       29",
"      </a>",
"      ]. Decreased mortality was associated with patients who exercised two to three and four to five times per week. However, for unclear reasons, daily exercise provided no survival benefit. Nonetheless, gradual increase in physical activity is probably beneficial in most dialysis patients and should be encouraged, unless there are specific medical contraindications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiovascular risk factor modification should be undertaken for dialysis patients, given that they are considered a coronary heart disease (CHD) equivalent. In dialysis patients, these measures are referred to as \"secondary prevention.\" (See",
"      <a class=\"local\" href=\"#H2\">",
"       'CHD risk equivalent'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview of secondary prevention'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      We recommend NOT initiating statin therapy in dialysis patients with no, mild or moderate increase in serum LDL-cholesterol levels, pending more definitive data (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We suggest continuing statin therapy in dialysis patients currently receiving these agents (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, some clinicians would withdraw statin therapy in dialysis patients based upon the lack of benefit. In dialysis patients with very high LDL-cholesterol levels, the initiation of statins may be reasonable. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Lipid modification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      These recommendations concerning the use of statins do not apply to patients with chronic kidney disease (CKD) who are not on dialysis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"       \"Chronic kidney disease and coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adverse outcomes appear to be generally associated with very high blood pressure in dialysis patients. We aim for a predialysis blood pressure value below",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      on minimal medications, if possible. However, this target blood pressure level should be individualized, partly depending upon symptoms of intradialytic hypotension. In some patients, targeting predialysis blood pressure of",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      may not be appropriate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20202?source=see_link\">",
"       \"Hypertension in dialysis patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      in dialysis patients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The dose of aspirin is 81",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      Dialysis patients who would prefer to avoid the increased risk of bleeding for an unproven cardiovascular benefit may reasonably choose to forgo aspirin therapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Aspirin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of beta blockers, ACE inhibitors, and angiotensin II receptor blockers for secondary prevention in dialysis patients is discussed in detail separately. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Beta blockers'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'ACE inhibitors or ARBs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among dialysis patients with abnormal",
"      <span class=\"nowrap\">",
"       calcium/phosphorus",
"      </span>",
"      metabolism, there are no convincing data from prospective randomized studies demonstrating a decrease in clinical events",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a survival advantage with any specific phosphorus binder or serum calcium x phosphorus product. Despite this, we generally aim for a calcium x phosphate product less than 55",
"      <span class=\"nowrap\">",
"       mg2/dL2",
"      </span>",
"      using current therapeutic options. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Mineral metabolism issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not administer any therapy for the purpose of improving cardiovascular outcomes by lowering homocysteine levels",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oxidative stress. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Hyperhomocysteinemia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Decreased oxidative stress'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend complete smoking cessation (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Dialysis patients may also benefit from a gradual increase in physical activity as tolerated. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Therapeutic lifestyle changes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/1\">",
"      Wanner C, Krane V, M&auml;rz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/2\">",
"      Herzog CA. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 2003; 14:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/3\">",
"      Afzali B, Haydar AA, Vinen K, Goldsmith DJ. From Finland to fatland: beneficial effects of statins for patients with chronic kidney disease. J Am Soc Nephrol 2004; 15:2161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/4\">",
"      Habib AN, Baird BC, Leypoldt JK, et al. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 2006; 21:2881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/5\">",
"      Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377:2181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/6\">",
"      M&auml;rz W, Genser B, Drechsler C, et al. Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol 2011; 6:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/7\">",
"      Fellstr&ouml;m BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/8\">",
"      Holdaas H, Holme I, Schmieder RE, et al. Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol 2011; 22:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/9\">",
"      Wanner C, Krane V. Sunrise of statins after AURORA and 4D? J Am Soc Nephrol 2011; 22:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/10\">",
"      Upadhyay A, Earley A, Lamont JL, et al. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012; 157:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/11\">",
"      Palmer SC, Craig JC, Navaneethan SD, et al. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012; 157:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/12\">",
"      Ethier J, Bragg-Gresham JL, Piera L, et al. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2007; 50:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/13\">",
"      Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 2009; 20:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/14\">",
"      Hiremath S, Holden RM, Fergusson D, Zimmerman DL. Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates. Clin J Am Soc Nephrol 2009; 4:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/15\">",
"      Palmer SC, Di Micco L, Razavian M, et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev 2013; 2:CD008834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/16\">",
"      Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007; 298:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/17\">",
"      Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/18\">",
"      Tepel M, van der Giet M, Statz M, et al. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003; 107:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/19\">",
"      Cal&ograve; LA, Naso A, Pagnin E, et al. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis--a molecular biological approach. Clin Nephrol 2004; 62:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/20\">",
"      Gordon CA, Himmelfarb J. Antioxidant therapy in uremia: evidence-based medicine? Semin Dial 2004; 17:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/21\">",
"      Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005; 20:2775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/22\">",
"      Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 2003; 63:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/23\">",
"      Svensson M, Schmidt EB, J&oslash;rgensen KA, et al. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 2006; 1:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/24\">",
"      Lok CE, Moist L, Hemmelgarn BR, et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 2012; 307:1809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/25\">",
"      Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int 2003; 63:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/26\">",
"      Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol 2005; 25:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/27\">",
"      Mc Causland FR, Brunelli SM, Waikar SS. Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis. Clin J Am Soc Nephrol 2012; 7:1827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/28\">",
"      Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int 2005; 25:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/34/554/abstract/29\">",
"      Stack AG, Molony DA, Rives T, et al. Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 2005; 45:690.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1962 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_554=[""].join("\n");
var outline_f0_34_554=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CHD RISK EQUIVALENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW OF SECONDARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LIPID MODIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Trials of statin therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - 4-D trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - AURORA trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23811909\">",
"      - SHARP trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H878000148\">",
"      - Meta-analyses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TRADITIONAL DRUG THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Aspirin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ACE inhibitors or ARBs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MINERAL METABOLISM ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      GLYCEMIC CONTROL IN DIABETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      HYPERHOMOCYSTEINEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DECREASED OXIDATIVE STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      FISH OIL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      THERAPEUTIC LIFESTYLE CHANGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=related_link\">",
"      ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=related_link\">",
"      Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13175?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in acute myocardial infarction: Recommendations for use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/53/11098?source=related_link\">",
"      Beta blockers in the management of acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=related_link\">",
"      Chronic kidney disease and coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43626?source=related_link\">",
"      Clinical trials of cholesterol lowering in patients with coronary heart disease or coronary risk equivalents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11288?source=related_link\">",
"      Evaluation of sudden cardiac arrest and sudden cardiac death in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/34/11817?source=related_link\">",
"      Glycemic control and vascular complications in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20202?source=related_link\">",
"      Hypertension in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29546?source=related_link\">",
"      Lipid abnormalities after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6248?source=related_link\">",
"      Lipid abnormalities in patients with chronic kidney disease not requiring dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/14/42217?source=related_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7865?source=related_link\">",
"      Management of hyperglycemia in diabetics with end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=related_link\">",
"      Myocardial dysfunction in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=related_link\">",
"      Nutritional antioxidants in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5576?source=related_link\">",
"      Overview of primary prevention of coronary heart disease and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=related_link\">",
"      Overview of sudden cardiac arrest and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=related_link\">",
"      Patient survival and maintenance dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29703?source=related_link\">",
"      Risk factors and epidemiology of coronary artery disease in end-stage renal disease (dialysis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30824?source=related_link\">",
"      Statins and chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7942?source=related_link\">",
"      Strategies other than treatment of stenosis to prevent thrombosis of hemodialysis vascular access grafts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9416?source=related_link\">",
"      Therapy of heart failure in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15945?source=related_link\">",
"      Treatment and prevention of sudden cardiac arrest in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33690?source=related_link\">",
"      Treatment of hyperphosphatemia in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12905?source=related_link\">",
"      Use of beta blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17738?source=related_link\">",
"      Vascular calcification in chronic kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_34_555="Cellular interstitial pneumonia";
var content_f0_34_555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of nonspecific or nonclassifiable cellular interstitial pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Connective tissue diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypersensitivity pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diffuse alveolar damage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infections",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_555=[""].join("\n");
var outline_f0_34_555=null;
var title_f0_34_556="Precipitants of HE in cirrhosis";
var content_f0_34_556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Precipitants of hepatic encephalopathy in patients with cirrhosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benzodiazepines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Narcotics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Increased ammonia production, absorption or entry into the brain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excess dietary intake of protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrolyte disturbances such as hypokalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic alkalosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Dehydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diuretics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large volume paracentesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Portosystemic shunting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiographic or surgically placed shunts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spontaneous shunts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Vascular occlusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Portal vein thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic vein thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary hepatocellular carcinoma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_556=[""].join("\n");
var outline_f0_34_556=null;
var title_f0_34_557="Safe food handling PI";
var content_f0_34_557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tips for safe food handling",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Purchase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not buy already-cooked food that is stored next to raw food, even if it is stored on ice.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not buy food in cans that are dented, cracked, or have a bulging lid.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Storage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Make sure meat and poultry products are refrigerated when bought.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use plastic bags to keep juices from meat and fish from touching other foods.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Store perishable items (that can go bad quickly) in the refrigerator within an hour of buying.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keep refrigerator temperature between 32 and 40&deg;F (0 and 4&deg;C) and freezer temperature at or below 0&deg;F (-18&deg;C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Freeze meat and poultry that will not be cooked within 48 hours.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Freeze tuna, bluefish and mahi-mahi that will not be cooked within 24 hours; other fish can be stored in the refrigerator for 48 hours.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not store eggs on the refrigerator door (since that is the warmest part of the refrigerator).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Put leftovers in the refrigerator within 2 hours of cooking them.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Divide leftovers into parts and store in small containers.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reheat leftovers to 165&deg;F (74&deg;C) before eating.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Preparation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wash hands with soap and water before cooking and after handling raw meat, poultry, fish, or raw eggs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thaw frozen meats and fish in the refrigerator or microwave, not by leaving them out.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marinate foods in the refrigerator, not at room temperature.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid contact of cooked foods with forks, spoons, knives, plates, or areas that may not be clean.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wash forks, spoons, knives, plates, and cutting areas with soap and water after they have touched raw meat, poultry, fish or eggs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid letting the juices from uncooked meat, poultry or fish touch cooked foods or foods that will be eaten raw.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carefully wash all fresh fruits and vegetables.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid recipes that include raw eggs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cooking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use a meat thermometer; cook beef and lamb to an internal temperature of 145&deg;F (63&deg;C), pork and ground beef to 160&deg;F (71&deg;C), and poultry to 170 to 180&deg;F (77 to 82&deg;C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cook eggs until the yolk begins to harden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boil juices from raw meat or fish before using on cooked food.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Serving",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serve cooked foods on clean plates with clean forks, spoons, and knives.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keep hot foods at 140&deg;F (60&deg;C) and cold foods below 40&deg;F (4&deg;C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Never leave foods at room temperature longer than 2 hours, or 1 hour if the room is hotter than 90&deg;F (32&deg;C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use coolers and ice packs to take perishable foods (that may go bad) away from home.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_34_557=[""].join("\n");
var outline_f0_34_557=null;
var title_f0_34_558="Contents: Pediatric medical emergencies";
var content_f0_34_558=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric medical emergencies",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric medical emergencies",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/16/21769\">",
"           Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/18/23848\">",
"           Acute viral encephalitis in children and adolescents: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/17/28951\">",
"           Definition and etiology of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/37/44633\">",
"           Elevated intracranial pressure in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/8/34950\">",
"           Emergency complications of Hirschsprung disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/45/4826\">",
"           Epiglottitis (supraglottitis): Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/16/12553\">",
"           Epiglottitis (supraglottitis): Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28074\">",
"           Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/14/22762\">",
"           Fever without a source in children 3 to 36 months of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/40/22152\">",
"           Management and evaluation of wide QRS complex tachycardia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/61/31705\">",
"           Peritonsillar cellulitis and abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43992\">",
"           Retropharyngeal infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/38/40550\">",
"           Strategies for the evaluation of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-5D4991A5C8-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f0_34_558=[""].join("\n");
var outline_f0_34_558=null;
var title_f0_34_559="Contents: Venous and pulmonary vascular";
var content_f0_34_559=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Venous and pulmonary vascular",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Venous and pulmonary vascular",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/48/38664\">",
"           Air embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/42/15016\">",
"           Amniotic fluid embolism syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/21/25942\">",
"           Fat embolism syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/58/36774\">",
"           Hepatopulmonary syndrome: Natural history, treatment, and outcomes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/35/3640\">",
"           Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/42/16042\">",
"           High altitude, air travel, and heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/32/32263\">",
"           Pulmonary arteriovenous malformations: Diagnostic evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/0/27656\">",
"           Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/4/12358\">",
"           Pulmonary arteriovenous malformations: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/46/23270\">",
"           Pulmonary tumor embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/7/39034\">",
"           Risks and side effects associated with estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/17/42266\">",
"           Therapeutic use of warfarin",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/31/14837\">",
"           Chronic thromboembolic pulmonary hypertension: Medical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/16/10503\">",
"           Chronic thromboembolic pulmonary hypertension: Surgical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/63/2041\">",
"           Clinical features and diagnosis of pulmonary hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/9/7320\">",
"           Clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/17/36119\">",
"           Cor pulmonale",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/4/38982\">",
"           Inhaled nitric oxide in adults with pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/47/19193\">",
"           Overview of pulmonary hypertension in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/31/34293\">",
"           Overview of the treatment of chronic thromboembolic pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/8/7304\">",
"           Pathogenesis of pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/15/35064\">",
"           Portopulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/22/12648\">",
"           Pulmonary hypertension associated with human immunodeficiency virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/31/16889\">",
"           Pulmonary hypertension associated with interstitial lung disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/49/6935\">",
"           Pulmonary vascular disease in systemic sclerosis (scleroderma): Definition, classification, risk factors, screening, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26342\">",
"           Pulmonary vascular disease in systemic sclerosis (scleroderma): Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/44/29385\">",
"           Pulmonary veno-occlusive disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/24/35210\">",
"           Treatment of pulmonary hypertension in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous insufficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/17/13592\">",
"           Clinical evaluation of lower extremity chronic venous disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/43/33462\">",
"           Diagnostic evaluation of chronic venous insufficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/41/32410\">",
"           Medical management of lower extremity chronic venous disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/22/43365\">",
"           Pathophysiology of chronic venous disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous thromboembolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/5/25690\">",
"           Anticoagulation in acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/26/27050\">",
"           Catheter-induced upper extremity venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/31/14837\">",
"           Chronic thromboembolic pulmonary hypertension: Medical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/16/10503\">",
"           Chronic thromboembolic pulmonary hypertension: Surgical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/9/7320\">",
"           Clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/27/39353\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/46/14055\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/57/6042\">",
"           Diagnosis of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/12/33994\">",
"           Diagnosis of suspected deep vein thrombosis of the lower extremity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/36/6730\">",
"           Drug-induced thrombosis and vascular disease in patients with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/1/28697\">",
"           Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/59/43961\">",
"           Low molecular weight heparin for venous thromboembolic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/50/35626\">",
"           Management of anticoagulation before and after elective surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/22/4456\">",
"           Overview of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/31/34293\">",
"           Overview of the treatment of chronic thromboembolic pulmonary hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/28/16840\">",
"           Placement of inferior vena cava filters and their complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/52/41802\">",
"           Prevention of venous thromboembolic disease in surgical patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/6/27754\">",
"           Primary (spontaneous) upper extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3273\">",
"           Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42503\">",
"           Treatment of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/24/35210\">",
"           Treatment of pulmonary hypertension in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-7A36055BEC-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f0_34_559=[""].join("\n");
var outline_f0_34_559=null;
